Podcasts about health office

This episode on the pellagra epidemic focuses on its prevalence in the U.S. in the early 20th century. Some of the scientific work done to understand it involves self-experimentation, and some of it is ethically problematic by today’s standards. Research: Akst, Daniel. “Pellagra: The Forgotten Plague.” American Heritage. December 2000. https://www.americanheritage.com/pellagra-forgotten-plague Baird Rattini, Kristin. “A Deadly Diet.” Discover. Mar2018, Vol. 39 Issue 2, p70-72. Bridges, Kenneth. “Pellagra.” Encyclopedia of Arkansas. https://encyclopediaofarkansas.net/entries/pellagra-2230/ Clay, Karen et al. “The Rise and Fall of Pellagra in the American South.” National Bureau of Economic Research Working Paper 23730. 2018. http://www.nber.org/papers/w23730 Cleveland Clinic. “Pellagra.” 07/18/2022. https://my.clevelandclinic.org/health/diseases/23905-pellagra Crabb, Mary Katherine. “An Epidemic of Pride: Pellagra and the Culture of the American South.” Anthropologica , 1992, Vol. 34, No. 1 (1992), pp. 89-103. Via JSTOR. https://www.jstor.org/stable/25605634 Flannery, Michael A. “’Frauds,’ ‘Filth Parties,’ ‘Yeast Fads,’ and ‘Black Boxes’: Pellagra and Southern Pride, 1906-2003.” The Southern Quarterly. Vol. 53, no.3/4 (Spring/Summer 2016). Gentilcore, David and Egidio Priani. “Pellagra and Pellagrous Insanity During the Long Nineteenth Century.” Mental Health in Historical Perspective. Palgrave Macmillan. 2023. Ginnaio, Monica. “Pellagra in Late Nineteenth Century Italy: Effects of a Deficiency Disease.” Population-E, 66 (3-4), 2011, 583-610. Hung, Putzer J. “Pellagra: A medical whodunit.” Hektoen International: A Journal of Medical Humanities. https://hekint.org/2018/09/18/pellagra-a-medical-whodunit/ Jaworek, Andrzej K. et al. “The history of pellagra.” Dermatol Rev/Przegl Dermatol 2021, 108, 554–566 DOI: https://doi.org/10.5114/dr.2021.114610 Kean, Sam. “Joseph Goldberger’s Filth Parties.” Science History Institute Museum and Library. https://www.sciencehistory.org/stories/magazine/joseph-goldbergers-filth-parties/ Kiple, Kenneth F. and Virginia H. “Black Tongue and Black Men: Pellagra and Slavery in the Antebellum South.” The Journal of Southern History , Aug., 1977, Vol. 43, No. 3. https://www.jstor.org/stable/2207649 Kraut, Alan. “Dr. Joseph Goldberger & the War on Pellagra.” National Institutes of Health Office of NIH History and Stetten Museum. https://history.nih.gov/pages/viewpage.action?pageId=8883184 Marks, Harry M. “Epidemiologists Explain Pellagra: Gender, Race and Political Economy in the Work of Edgar Sydenstricker.” Journal of the History of Medicine and Allied Sciences , JANUARY 2003. https://www.jstor.org/stable/24623836 Morabia, Alfredo. “Joseph Goldberger’s research on the prevention of pellagra.” J R Soc Med 2008: 101: 566–568. DOI 10.1258/jrsm.2008.08k010. Park, Youngmee K. et al. “Effectiveness of Food Fortification in the United States: The Case of Pellagra.” American Journal of Public Health. May 2U(H). Vol. 90. No. 5. Peres, Tanya M. “Malnourished.” Gravy. Southern Foodways Alliance. Fall 2016. https://www.southernfoodways.org/malnourished-cultural-ignorance-paved-the-way-for-pellagra/ Pinheiro, Hugo et al. “Hidden Hunger: A Pellagra Case Report.” Cureus vol. 13,4 e14682. 25 Apr. 2021, doi:10.7759/cureus.14682 A. C. Wollenberg. “Pellagra in Italy.” Public Health Reports (1896-1970), vol. 24, no. 30, 1909, pp. 1051–54. JSTOR, https://doi.org/10.2307/4563397. Accessed 13 Feb. 2025. Rajakumar, Kumaravel. “Pellagra in the United States: A Historical Perspective.” SOUTHERN MEDICAL JOURNAL • Vol. 93, No. 3. March 2020. Savvidou, Savvoula. “Pellagra: a non-eradicated old disease.” Clinics and practice vol. 4,1 637. 28 Apr. 2014, doi:10.4081/cp.2014.637 SEARCY GH. AN EPIDEMIC OF ACUTE PELLAGRA. JAMA. 1907;XLIX(1):37–38. doi:10.1001/jama.1907.25320010037002j Skelton, John. “Poverty or Privies? The Pellagra Controversy in America.” Fairmount Folio: Journal of History. Vol. 15 (2014). https://journals.wichita.edu/index.php/ff/article/view/151 Tharian, Bindu. "Pellagra." New Georgia Encyclopedia, 20 September 2004, https://www.georgiaencyclopedia.org/articles/science-medicine/pellagra/. University Libraries, University of South Carolina. “A Gospel of Health: Hilla Sheriff's Crusade Against Malnutrition in South Carolina.” https://digital.library.sc.edu/exhibits/hillasheriff/history-of-pellagra/ University of Alabama at Birmingham. “Pellagra in Alabama.” https://library.uab.edu/locations/reynolds/collections/regional-history/pellagra Wheeler, G.A. “A Note on the History of Pellagra in the United States.” Public Health Reports (1896-1970) , Sep. 18, 1931, Vol. 46, No. 38. Via JSTOR. https://www.jstor.org/stable/4580180 See omnystudio.com/listener for privacy information.

Dr. Gary Null provides a commentary on "Universal  Healthcare"       Universal Healthcare is the Solution to a Broken Medical System Gary Null, PhD Progressive Radio Network, March 3, 2025 For over 50 years, there has been no concerted or successful effort to bring down medical costs in the American healthcare system. Nor are the federal health agencies making disease prevention a priority. Regardless whether the political left or right sponsors proposals for reform, such measures are repeatedly defeated by both parties in Congress. As a result, the nation's healthcare system remains one of the most expensive and least efficient in the developed world. For the past 30 years, medical bills contributing to personal debt regularly rank among the top three causes of personal bankruptcy. This is a reality that reflects not only the financial strain on ordinary Americans but the systemic failure of the healthcare system itself. The urgent question is: If President Trump and his administration are truly seeking to reduce the nation's $36 trillion deficit, why is there no serious effort to reform the most bloated and corrupt sector of the economy? A key obstacle is the widespread misinformation campaign that falsely claims universal health care would cost an additional $2 trillion annually and further balloon the national debt. However, a more honest assessment reveals the opposite. If the US adopted a universal single-payer system, the nation could actually save up to $20 trillion over the next 10 years rather than add to the deficit. Even with the most ambitious efforts by people like Elon Musk to rein in federal spending or optimize government efficiency, the estimated savings would only amount to $500 billion. This is only a fraction of what could be achieved through comprehensive healthcare reform alone. Healthcare is the largest single expenditure of the federal budget. A careful examination of where the $5 trillion spent annually on healthcare actually goes reveals massive systemic fraud and inefficiency. Aside from emergency medicine, which accounts for only 10-12 percent of total healthcare expenditures, the bulk of this spending does not deliver better health outcomes nor reduce trends in physical and mental illness. Applying Ockham's Razor, the principle that the simplest solution is often the best, the obvious conclusion is that America's astronomical healthcare costs are the direct result of price gouging on an unimaginable scale. For example, in most small businesses, profit margins range between 1.6 and 2.5 percent, such as in grocery retail. Yet the pharmaceutical industrial complex routinely operates on markup rates as high as 150,000 percent for many prescription drugs. The chart below highlights the astronomical gap between the retail price of some top-selling patented pharmaceutical medications and their generic equivalents. Drug Condition Patent Price (per unit) Generic Price Estimated Manufacture Cost Markup Source Insulin (Humalog) Diabetes $300 $30 $3 10,000% Rand (2021) EpiPen Allergic reactions $600 $30 $10 6,000% BMJ (2022) Daraprim Toxoplasmosis $750/pill $2 $0.50 150,000% JAMA (2019) Harvoni Hepatitis C $94,500 (12 weeks) $30,000 $200 47,000% WHO Report (2018) Lipitor Cholesterol $150 $10 $0.50 29,900% Health Affairs (2020) Xarelto Blood Thinner $450 $25 $1.50 30,000% NEJM (2020) Abilify Schizophrenia $800 (30 tablets) $15 $2 39,900% AJMC (2019) Revlimid Cancer $16,000/mo $450 $150 10,500% Kaiser Health News (2021) Humira Arthritis $2,984/dose $400 $50 5,868% Rand (2021) Sovaldi Hepatitis C $1,000/pill $10 $2 49,900% JAMA (2021) Xolair Asthma $2,400/dose $300 $50 4,800% NEJM (2020) Gleevec Leukemia $10,000/mo $350 $200 4,900% Harvard Public Health Review (2020) OxyContin Pain Relief $600 (30 tablets) $15 $0.50 119,900% BMJ (2022) Remdesivir Covid-19 $3,120 (5 doses) N/A $10 31,100% The Lancet (2020) The corruption extends far beyond price gouging. Many pharmaceutical companies convince federal health agencies to fund their basic research and drug development with taxpayer dollars. Yet when these companies bring successful products to market, the profits are kept entirely by the corporations or shared with the agencies or groups of government scientists. On the other hand, the public, who funded the research, receives no financial return. This amounts to a systemic betrayal of the public trust on a scale of hundreds of billions of dollars annually. Another significant contributor to rising healthcare costs is the widespread practice of defensive medicine that is driven by the constant threat of litigation. Over the past 40 years, defensive medicine has become a cottage industry. Physicians order excessive diagnostic tests and unnecessary treatments simply to protect themselves from lawsuits. Study after study has shown that these over-performed procedures not only inflate costs but lead to iatrogenesis or medical injury and death caused by the medical  system and practices itself. The solution is simple: adopting no-fault healthcare coverage for everyone where patients receive care without needing to sue and thereby freeing doctors from the burden of excessive malpractice insurance. A single-payer universal healthcare system could fundamentally transform the entire industry by capping profits at every level — from drug manufacturers to hospitals to medical equipment suppliers. The Department of Health and Human Services would have the authority to set profit margins for medical procedures. This would ensure that healthcare is determined by outcomes, not profits. Additionally, the growing influence of private equity firms and vulture capitalists buying up hospitals and medical clinics across America must be reined in. These equity firms prioritize profit extraction over improving the quality of care. They often slash staff, raise prices, and dictate medical procedures based on what will yield the highest returns. Another vital reform would be to provide free medical education for doctors and nurses in exchange for five years of service under the universal system. Medical professionals would earn a realistic salary cap to prevent them from being lured into equity partnerships or charging exorbitant rates. The biggest single expense in the current system, however, is the private health insurance industry, which consumes 33 percent of the $5 trillion healthcare budget. Health insurance CEOs consistently rank among the highest-paid executives in the country. Their companies, who are nothing more than bean counters, decide what procedures and drugs will be covered, partially covered, or denied altogether. This entire industry is designed to place profits above patients' lives. If the US dismantled its existing insurance-based system and replaced it with a fully reformed national healthcare model, the country could save $2.7 trillion annually while simultaneously improving health outcomes. Over the course of 10 years, those savings would amount to $27 trillion. This could wipe out nearly the entire national debt in a short time. This solution has been available for decades but has been systematically blocked by corporate lobbying and bipartisan corruption in Washington. The path forward is clear but only if American citizens demand a system where healthcare is valued as a public service and not a commodity. The national healthcare crisis is not just a fiscal issue. It is a crucial moral failure of the highest order. With the right reforms, the nation could simultaneously restore its financial health and deliver the kind of healthcare system its citizens have long deserved. American Healthcare: Corrupt, Broken and Lethal Richard Gale and Gary Null Progressive Radio Network, March 3, 2025 For a nation that prides itself on being the world's wealthiest, most innovative and technologically advanced, the US' healthcare system is nothing less than a disaster and disgrace. Not only are Americans the least healthy among the most developed nations, but the US' health system ranks dead last among high-income countries. Despite rising costs and our unshakeable faith in American medical exceptionalism, average life expectancy in the US has remained lower than other OECD nations for many years and continues to decline. The United Nations recognizes healthcare as a human right. In 2018, former UN Secretary General Ban Ki-moon denounced the American healthcare system as "politically and morally wrong." During the pandemic it is estimated that two to three years was lost on average life expectancy. On the other hand, before the Covid-19 pandemic, countries with universal healthcare coverage found their average life expectancy stable or slowly increasing. The fundamental problem in the U.S. is that politics have been far too beholden to the pharmaceutical, HMO and private insurance industries. Neither party has made any concerted effort to reign in the corruption of corporate campaign funding and do what is sensible, financially feasible and morally correct to improve Americans' quality of health and well-being.   The fact that our healthcare system is horribly broken is proof that moneyed interests have become so powerful to keep single-payer debate out of the media spotlight and censored. Poll after poll shows that the American public favors the expansion of public health coverage. Other incremental proposals, including Medicare and Medicaid buy-in plans, are also widely preferred to the Affordable Care Act or Obamacare mess we are currently stuck with.   It is not difficult to understand how the dismal state of American medicine is the result of a system that has been sold out to the free-market and the bottom line interests of drug makers and an inflated private insurance industry. How advanced and ethically sound can a healthcare system be if tens of millions of people have no access to medical care because it is financially out of their reach?  The figures speak for themselves. The U.S. is burdened with a $41 trillion Medicare liability. The number of uninsured has declined during the past several years but still lingers around 25 million. An additional 30-35 million are underinsured. There are currently 65 million Medicare enrollees and 89 million Medicaid recipients. This is an extremely unhealthy snapshot of the country's ability to provide affordable healthcare and it is certainly unsustainable. The system is a public economic failure, benefiting no one except the large and increasingly consolidated insurance and pharmaceutical firms at the top that supervise the racket.   Our political parties have wrestled with single-payer or universal healthcare for decades. Obama ran his first 2008 presidential campaign on a single-payer platform. Since 1985, his campaign health adviser, the late Dr. Quentin Young from the University of Illinois Medical School, was one of the nation's leading voices calling for universal health coverage.  During a private conversation with Dr. Young shortly before his passing in 2016, he conveyed his sense of betrayal at the hands of the Obama administration. Dr. Young was in his 80s when he joined the Obama campaign team to help lead the young Senator to victory on a promise that America would finally catch up with other nations. The doctor sounded defeated. He shared how he was manipulated, and that Obama held no sincere intention to make universal healthcare a part of his administration's agenda. During the closed-door negotiations, which spawned the weak and compromised Affordable Care Act, Dr. Young was neither consulted nor invited to participate. In fact, he told us that he never heard from Obama again after his White House victory.   Past efforts to even raise the issue have been viciously attacked. A huge army of private interests is determined to keep the public enslaved to private insurers and high medical costs. The failure of our healthcare is in no small measure due to it being a fully for-profit operation. Last year, private health insurance accounted for 65 percent of coverage. Consider that there are over 900 private insurance companies in the US. National Health Expenditures (NHE) grew to $4.5 trillion in 2022, which was 17.3 percent of GDP. Older corporate rank-and-file Democrats and Republicans argue that a single-payer or socialized medical program is unaffordable. However, not only is single-payer affordable, it will end bankruptcies due to unpayable medical debt. In addition, universal healthcare, structured on a preventative model, will reduce disease rates at the outset.    Corporate Democrats argue that Obama's Affordable Care Act (ACA) was a positive step inching the country towards complete public coverage. However, aside from providing coverage to the poorest of Americans, Obamacare turned into another financial anchor around the necks of millions more. According to the health policy research group KFF, the average annual health insurance premium for single coverage is $8,400 and almost $24,000 for a family. In addition, patient out-of-pocket costs continue to increase, a 6.6% increase to $471 billion in 2022. Rather than healthcare spending falling, it has exploded, and the Trump and Biden administrations made matters worse.    Clearly, a universal healthcare program will require flipping the script on the entire private insurance industry, which employed over half a million people last year.  Obviously, the most volatile debate concerning a national universal healthcare system concerns cost. Although there is already a socialized healthcare system in place -- every federal legislator, bureaucrat, government employee and veteran benefits from it -- fiscal Republican conservatives and groups such as the Koch Brothers network are single-mindedly dedicated to preventing the expansion of Medicare and Medicaid. A Koch-funded Mercatus analysis made the outrageous claim that a single-payer system would increase federal health spending by $32 trillion in ten years. However, analyses and reviews by the Congressional Budget Office in the early 1990s concluded that such a system would only increase spending at the start; enormous savings would quickly offset it as the years pass. In one analysis, "the savings in administrative costs [10 percent of health spending] would be more than enough to offset the expense of universal coverage."    Defenders of those advocating for funding a National Health Program argue this can primarily be accomplished by raising taxes to levels comparable to other developed nations. This was a platform Senator Bernie Sanders and some of the younger progressive Democrats in the House campaigned on. The strategy was to tax the highest multimillion-dollar earners 60-70 percent. Despite the outrage of its critics, including old rank-and-file multi-millionaire Democrats like Nancy Pelosi and Chuck Schumer, this is still far less than in the past. During the Korean War, the top tax rate was 91 percent; it declined to 70 percent in the late 1960s. Throughout most of the 1970s, those in the lowest income bracket were taxed at 14 percent. We are not advocating for this strategy because it ignores where the funding is going, and the corruption in the system that is contributing to exorbitant waste.    But Democratic supporters of the ACA who oppose a universal healthcare plan ignore the additional taxes Obama levied to pay for the program. These included surtaxes on investment income, Medicare taxes from those earning over $200,000, taxes on tanning services, an excise tax on medical equipment, and a 40 percent tax on health coverage for costs over the designated cap that applied to flexible savings and health savings accounts. The entire ACA was reckless, sloppy and unnecessarily complicated from the start.    The fact that Obamacare further strengthened the distinctions between two parallel systems -- federal and private -- with entirely different economic structures created a labyrinth of red tape, rules, and wasteful bureaucracy. Since the ACA went into effect, over 150 new boards, agencies and programs have had to be established to monitor its 2,700 pages of gibberish. A federal single-payer system would easily eliminate this bureaucracy and waste.    A medical New Deal to establish universal healthcare coverage is a decisive step in the correct direction. But we must look at the crisis holistically and in a systematic way. Simply shuffling private insurance into a federal Medicare-for-all or buy-in program, funded by taxing the wealthiest of citizens, would only temporarily reduce costs. It will neither curtail nor slash escalating disease rates e. Any effective healthcare reform must also tackle the underlying reasons for Americans' poor state of health. We cannot shy away from examining the social illnesses infecting our entire free-market capitalist culture and its addiction to deregulation. A viable healthcare model would have to structurally transform how the medical economy operates. Finally, a successful medical New Deal must honestly evaluate the best and most reliable scientific evidence in order to effectively redirect public health spending.    For example, Dr. Ezekiel Emanuel, a former Obama healthcare adviser, observed that AIDS-HIV measures consume the most public health spending, even though the disease "ranked 75th on the list of diseases by personal health expenditures." On the other hand, according to the American Medical Association, a large percentage of the nation's $3.4 trillion healthcare spending goes towards treating preventable diseases, notably diabetes, common forms of heart disease, and back and neck pain conditions. In 2016, these three conditions were the most costly and accounted for approximately $277 billion in spending. Last year, the CDC announced the autism rate is now 1 in 36 children compared to 1 in 44 two years ago. A retracted study by Mark Blaxill, an autism activist at the Holland Center and a friend of the authors, estimates that ASD costs will reach $589 billion annually by 2030. There are no signs that this alarming trend will reverse and decline; and yet, our entire federal health system has failed to conscientiously investigate the underlying causes of this epidemic. All explanations that might interfere with the pharmaceutical industry's unchecked growth, such as over-vaccination, are ignored and viciously discredited without any sound scientific evidence. Therefore, a proper medical New Deal will require a systemic overhaul and reform of our federal health agencies, especially the HHS, CDC and FDA. Only the Robert Kennedy Jr presidential campaign is even addressing the crisis and has an inexpensive and comprehensive plan to deal with it. For any medical revolution to succeed in advancing universal healthcare, the plan must prioritize spending in a manner that serves public health and not private interests. It will also require reshuffling private corporate interests and their lobbyists to the sidelines, away from any strategic planning, in order to break up the private interests' control over federal agencies and its revolving door policies. Aside from those who benefit from this medical corruption, the overwhelming majority of Americans would agree with this criticism. However, there is a complete lack of national trust that our legislators, including the so-called progressives, would be willing to undertake such actions.    In addition, America's healthcare system ignores the single most critical initiative to reduce costs - that is, preventative efforts and programs instead of deregulation and closing loopholes designed to protect the drug and insurance industries' bottom line. Prevention can begin with banning toxic chemicals that are proven health hazards associated with current disease epidemics, and it can begin by removing a 1,000-plus toxins already banned in Europe. This should be a no-brainer for any legislator who cares for public health. For example, Stacy Malkan, co-founder of the Campaign for Safe Cosmetics, notes that "the policy approach in the US and Europe is dramatically different" when it comes to chemical allowances in cosmetic products. Whereas the EU has banned 1,328 toxic substances from the cosmetic industry alone, the US has banned only 11. The US continues to allow carcinogenic formaldehyde, petroleum, forever chemicals, many parabens (an estrogen mimicker and endocrine hormone destroyer), the highly allergenic p-phenylenediamine or PBD, triclosan, which has been associated with the rise in antibiotic resistant bacteria, avobenzone, and many others to be used in cosmetics, sunscreens, shampoo and hair dyes.   Next, the food Americans consume can be reevaluated for its health benefits. There should be no hesitation to tax the unhealthiest foods, such as commercial junk food, sodas and candy relying on high fructose corn syrup, products that contain ingredients proven to be toxic, and meat products laden with dangerous chemicals including growth hormones and antibiotics. The scientific evidence that the average American diet is contributing to rising disease trends is indisputable. We could also implement additional taxes on the public advertising of these demonstrably unhealthy products. All such tax revenue would accrue to a national universal health program to offset medical expenditures associated with the very illnesses linked to these products. Although such tax measures would help pay for a new medical New Deal, it may be combined with programs to educate the public about healthy nutrition if it is to produce a reduction in the most common preventable diseases. In fact, comprehensive nutrition courses in medical schools should be mandatory because the average physician receives no education in this crucial subject.  In addition, preventative health education should be mandatory throughout public school systems.   Private insurers force hospitals, clinics and private physicians into financial corners, and this is contributing to prodigious waste in money and resources. Annually, healthcare spending towards medical liability insurance costs tens of billions of dollars. In particular, this economic burden has taxed small clinics and physicians. It is well past the time that physician liability insurance is replaced with no-fault options. Today's doctors are spending an inordinate amount of money to protect themselves. Legions of liability and trial lawyers seek big paydays for themselves stemming from physician error. This has created a culture of fear among doctors and hospitals, resulting in the overly cautious practice of defensive medicine, driving up costs and insurance premiums just to avoid lawsuits. Doctors are forced to order unnecessary tests and prescribe more medications and medical procedures just to cover their backsides. No-fault insurance is a common-sense plan that enables physicians to pursue their profession in a manner that will reduce iatrogenic injuries and costs. Individual cases requiring additional medical intervention and loss of income would still be compensated. This would generate huge savings.    No other nation suffers from the scourge of excessive drug price gouging like the US. After many years of haggling to lower prices and increase access to generic drugs, only a minute amount of progress has been made in recent years. A 60 Minutes feature about the Affordable Care Act reported an "orgy of lobbying and backroom deals in which just about everyone with a stake in the $3-trillion-a-year health industry came out ahead—except the taxpayers.” For example, Life Extension magazine reported that an antiviral cream (acyclovir), which had lost its patent protection, "was being sold to pharmacies for 7,500% over the active ingredient cost. The active ingredient (acyclovir) costs only 8 pennies, yet pharmacies are paying a generic maker $600 for this drug and selling it to consumers for around $700." Other examples include the antibiotic Doxycycline. The price per pill averages 7 cents to $3.36 but has a 5,300 percent markup when it reaches the consumer. The antidepressant Clomipramine is marked up 3,780 percent, and the anti-hypertensive drug Captopril's mark-up is 2,850 percent. And these are generic drugs!    Medication costs need to be dramatically cut to allow drug manufacturers a reasonable but not obscene profit margin. By capping profits approximately 100 percent above all costs, we would save our system hundreds of billions of dollars. Such a measure would also extirpate the growing corporate misdemeanors of pricing fraud, which forces patients to pay out-of-pocket in order to make up for the costs insurers are unwilling to pay.    Finally, we can acknowledge that our healthcare is fundamentally a despotic rationing system based upon high insurance costs vis-a-vis a toss of the dice to determine where a person sits on the economic ladder. For the past three decades it has contributed to inequality. The present insurance-based economic metrics cast millions of Americans out of coverage because private insurance costs are beyond their means. Uwe Reinhardt, a Princeton University political economist, has called our system "brutal" because it "rations [people] out of the system." He defined rationing as "withholding something from someone that is beneficial." Discriminatory healthcare rationing now affects upwards to 60 million people who have been either priced out of the system or under insured. They make too much to qualify for Medicare under Obamacare, yet earn far too little to afford private insurance costs and premiums. In the final analysis, the entire system is discriminatory and predatory.    However, we must be realistic. Almost every member of Congress has benefited from Big Pharma and private insurance lobbyists. The only way to begin to bring our healthcare program up to the level of a truly developed nation is to remove the drug industry's rampant and unnecessary profiteering from the equation.     How did Fauci memory-hole a cure for AIDS and get away with it?   By Helen Buyniski   Over 700,000 Americans have died of AIDS since 1981, with the disease claiming some 42.3 million victims worldwide. While an HIV diagnosis is no longer considered a certain death sentence, the disease looms large in the public imagination and in public health funding, with contemporary treatments running into thousands of dollars per patient annually.   But was there a cure for AIDS all this time - an affordable and safe treatment that was ruthlessly suppressed and attacked by the US public health bureaucracy and its agents? Could this have saved millions of lives and billions of dollars spent on AZT, ddI and failed HIV vaccine trials? What could possibly justify the decision to disappear a safe and effective approach down the memory hole?   The inventor of the cure, Gary Null, already had several decades of experience creating healing protocols for physicians to help patients not responding well to conventional treatments by the time AIDS was officially defined in 1981. Null, a registered dietitian and board-certified nutritionist with a PhD in human nutrition and public health science, was a senior research fellow and Director of Anti-Aging Medicine at the Institute of Applied Biology for 36 years and has published over 950 papers, conducting groundbreaking experiments in reversing biological aging as confirmed with DNA methylation testing. Additionally, Null is a multi-award-winning documentary filmmaker, bestselling author, and investigative journalist whose work exposing crimes against humanity over the last 50 years has highlighted abuses by Big Pharma, the military-industrial complex, the financial industry, and the permanent government stay-behind networks that have come to be known as the Deep State.   Null was contacted in 1974 by Dr. Stephen Caiazza, a physician working with a subculture of gay men in New York living the so-called “fast track” lifestyle, an extreme manifestation of the gay liberation movement that began with the Stonewall riots. Defined by rampant sexual promiscuity and copious use of illegal and prescription drugs, including heavy antibiotic use for a cornucopia of sexually-transmitted diseases, the fast-track never included more than about two percent of gay men, though these dominated many of the bathhouses and clubs that defined gay nightlife in the era. These patients had become seriously ill as a result of their indulgence, generally arriving at the clinic with multiple STDs including cytomegalovirus and several types of herpes and hepatitis, along with candida overgrowth, nutritional deficiencies, gut issues, and recurring pneumonia. Every week for the next 10 years, Null would counsel two or three of these men - a total of 800 patients - on how to detoxify their bodies and de-stress their lives, tracking their progress with Caiazza and the other providers at weekly feedback meetings that he credits with allowing the team to quickly evaluate which treatments were most effective. He observed that it only took about two years on the “fast track” for a healthy young person to begin seeing muscle loss and the recurrent, lingering opportunistic infections that would later come to be associated with AIDS - while those willing to commit to a healthier lifestyle could regain their health in about a year.    It was with this background that Null established the Tri-State Healing Center in Manhattan in 1980, staffing the facility with what would eventually run to 22 certified health professionals to offer safe, natural, and effective low- and no-cost treatments to thousands of patients with HIV and AIDS-defining conditions. Null and his staff used variations of the protocols he had perfected with Caiazza's patients, a multifactorial patient-tailored approach that included high-dose vitamin C drips, intravenous ozone therapy, juicing and nutritional improvements and supplementation, aspects of homeopathy and naturopathy with some Traditional Chinese Medicine and Ayurvedic practices. Additional services offered on-site included acupuncture and holistic dentistry, while peer support groups were also held at the facility so that patients could find community and a positive environment, healing their minds and spirits while they healed their bodies.   “Instead of trying to kill the virus with antiretroviral pharmaceuticals designed to stop viral replication before it kills patients, we focused on what benefits could be gained by building up the patients' natural immunity and restoring biochemical integrity so the body could fight for itself,” Null wrote in a 2014 article describing the philosophy behind the Center's approach, which was wholly at odds with the pharmaceutical model.1   Patients were comprehensively tested every week, with any “recovery” defined solely by the labs, which documented AIDS patient after patient - 1,200 of them - returning to good health and reversing their debilitating conditions. Null claims to have never lost an AIDS patient in the Center's care, even as the death toll for the disease - and its pharmaceutical standard of care AZT - reached an all-time high in the early 1990s. Eight patients who had opted for a more intensive course of treatment - visiting the Center six days a week rather than one - actually sero-deconverted, with repeated subsequent testing showing no trace of HIV in their bodies.   As an experienced clinical researcher himself, Null recognized that any claims made by the Center would be massively scrutinized, challenging as they did the prevailing scientific consensus that AIDS was an incurable, terminal illness. He freely gave his protocols to any medical practitioner who asked, understanding that his own work could be considered scientifically valid only if others could replicate it under the same conditions. After weeks of daily observational visits to the Center, Dr. Robert Cathcart took the protocols back to San Francisco, where he excitedly reported that patients were no longer dying in his care.    Null's own colleague at the Institute of Applied Biology, senior research fellow Elana Avram, set up IV drip rooms at the Institute and used his intensive protocols to sero-deconvert 10 patients over a two-year period. While the experiment had been conducted in secret, as the Institute had been funded by Big Pharma since its inception half a century earlier, Avram had hoped she would be able to publish a journal article to further publicize Null's protocols and potentially help AIDS patients, who were still dying at incredibly high rates thanks to Burroughs Wellcome's noxious but profitable AZT. But as she would later explain in a 2019 letter to Null, their groundbreaking research never made it into print - despite meticulous documentation of their successes - because the Institute's director and board feared their pharmaceutical benefactors would withdraw the funding on which they depended, given that Null's protocols did not involve any patentable or otherwise profitable drugs. When Avram approached them about publication, the board vetoed the idea, arguing that it would “draw negative attention because [the work] was contrary to standard drug treatments.” With no real point in continuing experiments along those lines without institutional support and no hope of obtaining funding from elsewhere, the department she had created specifically for these experiments shut down after a two-year followup with her test subjects - all of whom remained alive and healthy - was completed.2   While the Center was receiving regular visits by this time from medical professionals and, increasingly, black celebrities like Stokely Carmichael and Isaac Hayes, who would occasionally perform for the patients, the news was spreading by word of mouth alone - not a single media outlet had dared to document the clinic that was curing AIDS patients for free. Instead, they gave airtime to Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases, who had for years been spreading baseless, hysteria-fueling claims about HIV and AIDS to any news outlet that would put him on. His claim that children could contract the virus from “ordinary household conduct” with an infected relative proved so outrageous he had to walk it back,3 and he never really stopped insisting the deadly plague associated with gays and drug users was about to explode like a nuclear bomb among the law-abiding heterosexual population. Fauci by this time controlled all government science funding through NIAID, and his zero-tolerance approach to dissent on the HIV/AIDS front had already seen prominent scientists like virologist Peter Duesberg stripped of the resources they needed for their work because they had dared to question his commandment: There is no cause of AIDS but HIV, and AZT is its treatment. Even the AIDS activist groups, which by then had been coopted by Big Pharma and essentially reduced to astroturfing for the toxic failed chemotherapy drug AZT backed by the institutional might of Fauci's NIAID,4 didn't seem to want to hear that there was a cure. Unconcerned with the irrationality of denouncing the man touting his free AIDS cure as an  “AIDS denier,” they warned journalists that platforming Null or anyone else rejecting the mainstream medical line would be met with organized demands for their firing.    Determined to breach the institutional iron curtain and get his message to the masses, Null and his team staged a press conference in New York, inviting scientists and doctors from around the world to share their research on alternative approaches to HIV and AIDS in 1993. To emphasize the sound scientific basis of the Center's protocols and encourage guests to adopt them into their own practices, Null printed out thousands of abstracts in support of each nutrient and treatment being used. However, despite over 7,000 invitations sent three times to major media, government figures, scientists, and activists, almost none of the intended audience members showed up. Over 100 AIDS patients and their doctors, whose charts exhaustively documented their improvements using natural and nontoxic modalities over the preceding 12 months, gave filmed testimonials, declaring that the feared disease was no longer a death sentence, but the conference had effectively been silenced. Bill Tatum, publisher of the Amsterdam News, suggested Null and his patients would find a more welcoming audience in his home neighborhood of Harlem - specifically, its iconic Apollo Theatre. For three nights, the theater was packed to capacity. Hit especially hard by the epidemic and distrustful of a medical system that had only recently stopped being openly racist (the Tuskegee syphilis experiment only ended in 1972), black Americans, at least, did not seem to care what Anthony Fauci would do if he found out they were investigating alternatives to AZT and death.    PBS journalist Tony Brown, having obtained a copy of the video of patient testimonials from the failed press conference, was among a handful of black journalists who began visiting the Center to investigate the legitimacy of Null's claims. Satisfied they had something significant to offer his audience, Brown invited eight patients - along with Null himself - onto his program over the course of several episodes to discuss the work. It was the first time these protocols had received any attention in the media, despite Null having released nearly two dozen articles and multiple documentaries on the subject by that time. A typical patient on one program, Al, a recovered IV drug user who was diagnosed with AIDS at age 32, described how he “panicked,” saw a doctor and started taking AZT despite his misgivings - only to be forced to discontinue the drug after just a few weeks due to his condition deteriorating rapidly. Researching alternatives brought him to Null, and after six months of “detoxing [his] lifestyle,” he observed his initial symptoms - swollen lymph nodes and weight loss - begin to reverse, culminating with sero-deconversion. On Bill McCreary's Channel 5 program, a married couple diagnosed with HIV described how they watched their T-cell counts increase as they cut out sugar, caffeine, smoking, and drinking and began eating a healthy diet. They also saw the virus leave their bodies.   For HIV-positive viewers surrounded by fear and negativity, watching healthy-looking, cheerful “AIDS patients” detail their recovery while Null backed up their claims with charts must have been balm for the soul. But the TV programs were also a form of outreach to the medical community, with patients' charts always on hand to convince skeptics the cure was scientifically valid. Null brought patients' charts to every program, urging them to keep an open mind: “Other physicians and public health officials should know that there's good science in the alternative perspective. It may not be a therapy that they're familiar with, because they're just not trained in it, but if the results are positive, and you can document them…” He challenged doubters to send in charts from their own sero-deconverted patients on AZT, and volunteered to debate proponents of the orthodox treatment paradigm - though the NIH and WHO both refused to participate in such a debate on Tony Brown's Journal, following Fauci's directive prohibiting engagement with forbidden ideas.    Aside from those few TV programs and Null's own films, suppression of Null's AIDS cure beyond word of mouth was total. The 2021 documentary The Cost of Denial, produced by the Society for Independent Journalists, tells the story of the Tri-State Healing Center and the medical paradigm that sought to destroy it, lamenting the loss of the lives that might have been saved in a more enlightened society. Nurse practitioner Luanne Pennesi, who treated many of the AIDS patients at the Center, speculated in the film that the refusal by the scientific establishment and AIDS activists to accept their successes was financially motivated. “It was as if they didn't want this information to get out. Understand that our healthcare system as we know it is a corporation, it's a corporate model, and it's about generating revenue. My concern was that maybe they couldn't generate enough revenue from these natural approaches.”5   Funding was certainly the main disciplinary tool Fauci's NIAID used to keep the scientific community in line. Despite the massive community interest in the work being done at the Center, no foundation or institution would defy Fauci and risk getting itself blacklisted, leaving Null to continue funding the operation out of his pocket with the profits from book sales. After 15 years, he left the Center in 1995, convinced the mainstream model had so thoroughly been institutionalized that there was no chance of overthrowing it. He has continued to counsel patients and advocate for a reappraisal of the HIV=AIDS hypothesis and its pharmaceutical treatments, highlighting the deeply flawed science underpinning the model of the disease espoused by the scientific establishment in 39 articles, six documentaries and a 700-page textbook on AIDS, but the Center's achievements have been effectively memory-holed by Fauci's multi-billion-dollar propaganda apparatus.     FRUIT OF THE POISONOUS TREE   To understand just how much of a threat Null's work was to the HIV/AIDS establishment, it is instructive to revisit the 1984 paper, published by Dr. Robert Gallo of the National Cancer Institute, that established HIV as the sole cause of AIDS. The CDC's official recognition of AIDS in 1981 had done little to quell the mounting public panic over the mysterious illness afflicting gay men in the US, as the agency had effectively admitted it had no idea what was causing them to sicken and die. As years passed with no progress determining the causative agent of the plague, activist groups like Gay Men's Health Crisis disrupted public events and threatened further mass civil disobedience as they excoriated the NIH for its sluggish allocation of government science funding to uncovering the cause of the “gay cancer.”6 When Gallo published his paper declaring that the retrovirus we now know as HIV was the sole “probable” cause of AIDS, its simple, single-factor hypothesis was the answer to the scientific establishment's prayers. This was particularly true for Fauci, as the NIAID chief was able to claim the hot new disease as his agency's own domain in what has been described as a “dramatic confrontation” with his rival Sam Broder at the National Cancer Institute. After all, Fauci pointed out, Gallo's findings - presented by Health and Human Services Secretary Margaret Heckler as if they were gospel truth before any other scientists had had a chance to inspect them, never mind conduct a full peer review - clearly classified AIDS as an infectious disease, and not a cancer like the Kaposi's sarcoma which was at the time its most visible manifestation. Money and media attention began pouring in, even as funding for the investigation of other potential causes of AIDS dried up. Having already patented a diagnostic test for “his” retrovirus before introducing it to the world, Gallo was poised for a financial windfall, while Fauci was busily leveraging the discovery into full bureaucratic empire of the US scientific apparatus.   While it would serve as the sole basis for all US government-backed AIDS research to follow - quickly turning Gallo into the most-cited scientist in the world during the 1980s,7 Gallo's “discovery” of HIV was deeply problematic. The sample that yielded the momentous discovery actually belonged to Prof. Luc Montagnier of the French Institut Pasteur, a fact Gallo finally admitted in 1991, four years after a lawsuit from the French government challenged his patent on the HIV antibody test, forcing the US government to negotiate a hasty profit-sharing agreement between Gallo's and Montagnier's labs. That lawsuit triggered a cascade of official investigations into scientific misconduct by Gallo, and evidence submitted during one of these probes, unearthed in 2008 by journalist Janine Roberts, revealed a much deeper problem with the seminal “discovery.” While Gallo's co-author, Mikulas Popovic, had concluded after numerous experiments with the French samples that the virus they contained was not the cause of AIDS, Gallo had drastically altered the paper's conclusion, scribbling his notes in the margins, and submitted it for publication to the journal Science without informing his co-author.   After Roberts shared her discovery with contacts in the scientific community, 37 scientific experts wrote to the journal demanding that Gallo's career-defining HIV paper be retracted from Science for lacking scientific integrity.8 Their call, backed by an endorsement from the 2,600-member scientific organization Rethinking AIDS, was ignored by the publication and by the rest of mainstream science despite - or perhaps because of - its profound implications.   That 2008 letter, addressed to Science editor-in-chief Bruce Alberts and copied to American Association for the Advancement of Science CEO Alan Leshner, is worth reproducing here in its entirety, as it utterly dismantles Gallo's hypothesis - and with them the entire HIV is the sole cause of AIDS dogma upon which the contemporary medical model of the disease rests:   On May 4, 1984 your journal published four papers by a group led by Dr. Robert Gallo. We are writing to express our serious concerns with regard to the integrity and veracity of the lead paper among these four of which Dr. Mikulas Popovic is the lead author.[1] The other three are also of concern because they rely upon the conclusions of the lead paper .[2][3][4]  In the early 1990s, several highly critical reports on the research underlying these papers were produced as a result of governmental inquiries working under the supervision of scientists nominated by the National Academy of Sciences and the Institute of Medicine. The Office of Research Integrity of the US Department of Health and Human Services concluded that the lead paper was “fraught with false and erroneous statements,” and that the “ORI believes that the careless and unacceptable keeping of research records...reflects irresponsible laboratory management that has permanently impaired the ability to retrace the important steps taken.”[5] Further, a Congressional Subcommittee on Oversight and Investigations led by US Representative John D. Dingell of Michigan produced a staff report on the papers which contains scathing criticisms of their integrity.[6]  Despite the publically available record of challenges to their veracity, these papers have remained uncorrected and continue to be part of the scientific record.  What prompts our communication today is the recent revelation of an astonishing number of previously unreported deletions and unjustified alterations made by Gallo to the lead paper. There are several documents originating from Gallo's laboratory that, while available for some time, have only recently been fully analyzed. These include a draft of the lead paper typewritten by Popovic which contains handwritten changes made to it by Gallo.[7] This draft was the key evidence used in the above described inquiries to establish that Gallo had concealed his laboratory's use of a cell culture sample (known as LAV) which it received from the Institut Pasteur.  These earlier inquiries verified that the typed manuscript draft was produced by Popovic who had carried out the recorded experiment while his laboratory chief, Gallo, was in Europe and that, upon his return, Gallo changed the document by hand a few days before it was submitted to Science on March 30, 1984. According to the ORI investigation, “Dr. Gallo systematically rewrote the manuscript for what would become a renowned LTCB [Gallo's laboratory at the National Cancer Institute] paper.”[5]  This document provided the important evidence that established the basis for awarding Dr. Luc Montagnier and Dr. Francoise Barré-Sinoussi the 2008 Nobel Prize in Medicine for the discovery of the AIDS virus by proving it was their samples of LAV that Popovic used in his key experiment. The draft reveals that Popovic had forthrightly admitted using the French samples of LAV renamed as Gallo's virus, HTLV-III, and that Gallo had deleted this admission, concealing their use of LAV.  However, it has not been previously reported that on page three of this same document Gallo had also deleted Popovic's unambiguous statement that, "Despite intensive research efforts, the causative agent of AIDS has not yet been identified,” replacing it in the published paper with a statement that said practically the opposite, namely, “That a retrovirus of the HTLV family might be an etiologic agent of AIDS was suggested by the findings.”  It is clear that the rest of Popovic's typed paper is entirely consistent with his statement that the cause of AIDS had not been found, despite his use of the French LAV. Popovic's final conclusion was that the culture he produced “provides the possibility” for detailed studies. He claimed to have achieved nothing more. At no point in his paper did Popovic attempt to prove that any virus caused AIDS, and it is evident that Gallo concealed these key elements in Popovic's experimental findings.  It is astonishing now to discover these unreported changes to such a seminal document. We can only assume that Gallo's alterations of Popovic's conclusions were not highlighted by earlier inquiries because the focus at the time was on establishing that the sample used by Gallo's lab came from Montagnier and was not independently collected by Gallo. In fact, the only attention paid to the deletions made by Gallo pertains to his effort to hide the identity of the sample. The questions of whether Gallo and Popovic's research proved that LAV or any other virus was the cause of AIDS were clearly not considered.  Related to these questions are other long overlooked documents that merit your attention. One of these is a letter from Dr. Matthew A. Gonda, then Head of the Electron Microscopy Laboratory at the National Cancer Institute, which is addressed to Popovic, copied to Gallo and dated just four days prior to Gallo's submission to Science.[8] In this letter, Gonda remarks on samples he had been sent for imaging because “Dr Gallo wanted these micrographs for publication because they contain HTLV.” He states, “I do not believe any of the particles photographed are of HTLV-I, II or III.” According to Gonda, one sample contained cellular debris, while another had no particles near the size of a retrovirus. Despite Gonda's clearly worded statement, Science published on May 4, 1984 papers attributed to Gallo et al with micrographs attributed to Gonda and described unequivocally as HTLV-III.  In another letter by Gallo, dated one day before he submitted his papers to Science, Gallo states, “It's extremely rare to find fresh cells [from AIDS patients] expressing the virus... cell culture seems to be necessary to induce virus,” a statement which raises the possibility he was working with a laboratory artifact. [9]  Included here are copies of these documents and links to the same. The very serious flaws they reveal in the preparation of the lead paper published in your journal in 1984 prompts our request that this paper be withdrawn. It appears that key experimental findings have been concealed. We further request that the three associated papers published on the same date also be withdrawn as they depend on the accuracy of this paper.  For the scientific record to be reliable, it is vital that papers shown to be flawed, or falsified be retracted. Because a very public record now exists showing that the Gallo papers drew unjustified conclusions, their withdrawal from Science is all the more important to maintain integrity. Future researchers must also understand they cannot rely on the 1984 Gallo papers for statements about HIV and AIDS, and all authors of papers that previously relied on this set of four papers should have the opportunity to consider whether their own conclusions are weakened by these revelations.      Gallo's handwritten revision, submitted without his colleague's knowledge despite multiple experiments that failed to support the new conclusion, was the sole foundation for the HIV=AIDS hypothesis. Had Science published the manuscript the way Popovic had typed it, there would be no AIDS “pandemic” - merely small clusters of people with AIDS. Without a viral hypothesis backing the development of expensive and deadly pharmaceuticals, would Fauci have allowed these patients to learn about the cure that existed all along?   Faced with a potential rebellion, Fauci marshaled the full resources under his control to squelch the publication of the investigations into Gallo and restrict any discussion of competing hypotheses in the scientific and mainstream press, which had been running virus-scare stories full-time since 1984. The effect was total, according to biochemist Dr. Kary Mullis, inventor of the polymerase chain reaction (PCR) procedure. In a 2009 interview, Mullis recalled his own shock when he attempted to unearth the experimental basis for the HIV=AIDS hypothesis. Despite his extensive inquiry into the literature, “there wasn't a scientific reference…[that] said ‘here's how come we know that HIV is the probable cause of AIDS.' There was nothing out there like that.”9 This yawning void at the core of HIV/AIDS “science" turned him into a strident critic of AIDS dogma - and those views made him persona non grata where the scientific press was concerned, suddenly unable to publish a single paper despite having won the Nobel Prize for his invention of the PCR test just weeks before.  10   DISSENT BECOMES “DENIAL”   While many of those who dissent from the orthodox HIV=AIDS view believe HIV plays a role in the development of AIDS, they point to lifestyle and other co-factors as being equally if not more important. Individuals who test positive for HIV can live for decades in perfect health - so long as they don't take AZT or the other toxic antivirals fast-tracked by Fauci's NIAID - but those who developed full-blown AIDS generally engaged in highly risky behaviors like extreme promiscuity and prodigious drug abuse, contracting STDs they took large quantities of antibiotics to treat, further running down their immune systems. While AIDS was largely portrayed as a “gay disease,” it was only the “fast track” gays, hooking up with dozens of partners nightly in sex marathons fueled by “poppers” (nitrate inhalants notorious for their own devastating effects on the immune system), who became sick. Kaposi's sarcoma, one of the original AIDS-defining conditions, was widespread among poppers-using gay men, but never appeared among IV drug users or hemophiliacs, the other two main risk groups during the early years of the epidemic. Even Robert Gallo himself, at a 1994 conference on poppers held by the National Institute on Drug Abuse, would admit that the previously-rare form of skin cancer surging among gay men was not primarily caused by HIV - and that it was immune stimulation, rather than suppression, that was likely responsible.11 Similarly, IV drug users are often riddled with opportunistic infections as their habit depresses the immune system and their focus on maintaining their addiction means that healthier habits - like good nutrition and even basic hygiene - fall by the wayside.    Supporting the call for revising the HIV=AIDS hypothesis to include co-factors is the fact that the mass heterosexual outbreaks long predicted by Fauci and his ilk in seemingly every country on Earth have failed to materialize, except - supposedly - in Africa, where the diagnostic standard for AIDS differs dramatically from those of the West. Given the prohibitively high cost of HIV testing for poor African nations, the WHO in 1985 crafted a diagnostic loophole that became known as the “Bangui definition,” allowing medical professionals to diagnose AIDS in the absence of a test using just clinical symptoms: high fever, persistent cough, at least 30 days of diarrhea, and the loss of 10% of one's body weight within two months. Often suffering from malnutrition and without access to clean drinking water, many of the inhabitants of sub-Saharan Africa fit the bill, especially when the WHO added tuberculosis to the list of AIDS-defining illnesses in 1993 - a move which may be responsible for as many as one half of African “AIDS” cases, according to journalist Christine Johnson. The WHO's former Chief of Global HIV Surveillance, James Chin, acknowledged their manipulation of statistics, but stressed that it was the entire AIDS industry - not just his organization - perpetrating the fraud. “There's the saying that, if you knew what sausages are made of, most people would hesitate to sort of eat them, because they wouldn't like what's in it. And if you knew how HIV/AIDS numbers are cooked, or made up, you would use them with extreme caution,” Chin told an interviewer in 2009.12   With infected numbers stubbornly remaining constant in the US despite Fauci's fearmongering projections of the looming heterosexually-transmitted plague, the CDC in 1993 broadened its definition of AIDS to include asymptomatic (that is, healthy) HIV-positive people with low T-cell counts - an absurd criteria given that an individual's T-cell count can fluctuate by hundreds within a single day. As a result, the number of “AIDS cases” in the US immediately doubled. Supervised by Fauci, the NIAID had been quietly piling on diseases into the “AIDS-related” category for years, bloating the list from just two conditions - pneumocystis carinii pneumonia and Kaposi's sarcoma - to 30 so fast it raised eyebrows among some of science's leading lights. Deeming the entire process “bizarre” and unprecedented, Kary Mullis wondered aloud why no one had called the AIDS establishment out: “There's something wrong here. And it's got to be financial.”13   Indeed, an early CDC public relations campaign was exposed by the Wall Street Journal in 1987 as having deliberately mischaracterized AIDS as a threat to the entire population so as to garner increased public and private funding for what was very much a niche issue, with the risk to average heterosexuals from a single act of sex “smaller than the risk of ever getting hit by lightning.” Ironically, the ads, which sought to humanize AIDS patients in an era when few Americans knew anyone with the disease and more than half the adult population thought infected people should be forced to carry cards warning of their status, could be seen as a reaction to the fear tactics deployed by Fauci early on.14   It's hard to tell where fraud ends and incompetence begins with Gallo's HIV antibody test. Much like Covid-19 would become a “pandemic of testing,” with murder victims and motorcycle crashes lumped into “Covid deaths” thanks to over-sensitized PCR tests that yielded as many as 90% false positives,15 HIV testing is fraught with false positives - and unlike with Covid-19, most people who hear they are HIV-positive still believe they are receiving a death sentence. Due to the difficulty of isolating HIV itself from human samples, the most common diagnostic tests, ELISA and the Western Blot, are designed to detect not the virus but antibodies to it, upending the traditional medical understanding that the presence of antibodies indicates only exposure - and often that the body has actually vanquished the pathogen. Patients are known to test positive for HIV antibodies in the absence of the virus due to at least 70 other conditions, including hepatitis, lupus, rheumatoid arthritis, syphilis, recent vaccination or even pregnancy. (https://www.chcfl.org/diseases-that-can-cause-a-false-positive-hiv-test/) Positive results are often followed up with a PCR “viral load” test, even though the inventor of the PCR technique Kary Mullis famously condemned its misuse as a tool for diagnosing infection. Packaging inserts for all three tests warn the user that they cannot be reliably used to diagnose HIV.16 The ELISA HIV antibody test explicitly states: “At present there is no recognized standard for establishing the presence and absence of HIV antibody in human blood.”17   That the public remains largely unaware of these and other massive holes in the supposedly airtight HIV=AIDS=DEATH paradigm is a testament to Fauci's multi-layered control of the press. Like the writers of the Great Barrington Declaration and other Covid-19 dissidents, scientists who question HIV/AIDS dogma have been brutally punished for their heresy, no matter how prestigious their prior standing in the field and no matter how much evidence they have for their own claims. In 1987, the year the FDA's approval of AZT made AIDS the most profitable epidemic yet (a dubious designation Covid-19 has since surpassed), Fauci made it clearer than ever that scientific inquiry and debate - the basis of the scientific method - would no longer be welcome in the American public health sector, eliminating retrovirologist Peter Duesberg, then one of the most prominent opponents of the HIV=AIDS hypothesis, from the scientific conversation with a professional disemboweling that would make a cartel hitman blush. Duesberg had just eviscerated Gallo's 1984 HIV paper with an article of his own in the journal Cancer Research, pointing out that retroviruses had never before been found to cause a single disease in humans - let alone 30 AIDS-defining diseases. Rather than allow Gallo or any of the other scientists in his camp to respond to the challenge, Fauci waged a scorched-earth campaign against Duesberg, who had until then been one of the most highly regarded researchers in his field. Every research grant he requested was denied; every media appearance was canceled or preempted. The University of California at Berkeley, unable to fully fire him due to tenure, took away his lab, his graduate students, and the rest of his funding. The few colleagues who dared speak up for him in public were also attacked, while enemies and opportunists were encouraged to slander Duesberg at the conferences he was barred from attending and in the journals that would no longer publish his replies. When Duesberg was summoned to the White House later that year by then-President Ronald Reagan to debate Fauci on the origins of AIDS, Fauci convinced the president to cancel, allegedly pulling rank on the Commander-in-Chief with an accusation that the “White House was interfering in scientific matters that belonged to the NIH and the Office of Science and Technology Assessment.” After seven years of this treatment, Duesberg was contacted by NIH official Stephen O'Brien and offered an escape from professional purgatory. He could have “everything back,” he was told, and shown a manuscript of a scientific paper - apparently commissioned by the editor of the journal Nature - “HIV Causes AIDS: Koch's Postulates Fulfilled” with his own name listed alongside O'Brien's as an author.18 His refusal to take the bribe effectively guaranteed the epithet “AIDS denier” will appear on his tombstone. The character assassination of Duesberg became a template that would be deployed to great effectiveness wherever Fauci encountered dissent - never debate, only demonize, deplatform and destroy.    Even Luc Montagnier, the real discoverer of HIV, soon found himself on the wrong side of the Fauci machine. With his 1990 declaration that “the HIV virus [by itself] is harmless and passive, a benign virus,” Montagnier began distancing himself from Gallo's fraud, effectively placing a target on his own back. In a 1995 interview, he elaborated: “four factors that have come together to account for the sudden epidemic [of AIDS]: HIV presence, immune hyper-activation, increased sexually transmitted disease incidence, sexual behavior changes and other behavioral changes” such as drug use, poor nutrition and stress - all of which he said had to occur “essentially simultaneously” for HIV to be transmitted, creating the modern epidemic. Like the professionals at the Tri-State Healing Center, Montagnier advocated for the use of antioxidants like vitamin C and N-acetyl cysteine, naming oxidative stress as a critical factor in the progression from HIV to AIDS.19 When Montagnier died in 2022, Fauci's media mouthpieces sneered that the scientist (who was awarded the Nobel Prize in 2008 for his discovery of HIV, despite his flagging faith in that discovery's significance) “started espousing views devoid of a scientific basis” in the late 2000s, leading him to be “shunned by the scientific community.”20 In a particularly egregious jab, the Washington Post's obit sings the praises of Robert Gallo, implying it was the American scientist who really should have won the Nobel for HIV, while dismissing as “

The pellagra epidemic of the early 20th century may have been the deadliest epidemic of a specific nutrient deficiency in U.S. history. Part one covers what it is, its appearance in 19th-century Italy, and the first reports of it in the U.S. Research: Akst, Daniel. “Pellagra: The Forgotten Plague.” American Heritage. December 2000. https://www.americanheritage.com/pellagra-forgotten-plague Baird Rattini, Kristin. “A Deadly Diet.” Discover. Mar2018, Vol. 39 Issue 2, p70-72. Bridges, Kenneth. “Pellagra.” Encyclopedia of Arkansas. https://encyclopediaofarkansas.net/entries/pellagra-2230/ Clay, Karen et al. “The Rise and Fall of Pellagra in the American South.” National Bureau of Economic Research Working Paper 23730. 2018. http://www.nber.org/papers/w23730 Cleveland Clinic. “Pellagra.” 07/18/2022. https://my.clevelandclinic.org/health/diseases/23905-pellagra Crabb, Mary Katherine. “An Epidemic of Pride: Pellagra and the Culture of the American South.” Anthropologica , 1992, Vol. 34, No. 1 (1992), pp. 89-103. Via JSTOR. https://www.jstor.org/stable/25605634 Flannery, Michael A. “’Frauds,’ ‘Filth Parties,’ ‘Yeast Fads,’ and ‘Black Boxes’: Pellagra and Southern Pride, 1906-2003.” The Southern Quarterly. Vol. 53, no.3/4 (Spring/Summer 2016). Gentilcore, David and Egidio Priani. “Pellagra and Pellagrous Insanity During the Long Nineteenth Century.” Mental Health in Historical Perspective. Palgrave Macmillan. 2023. Ginnaio, Monica. “Pellagra in Late Nineteenth Century Italy: Effects of a Deficiency Disease.” Population-E, 66 (3-4), 2011, 583-610. Hung, Putzer J. “Pellagra: A medical whodunit.” Hektoen International: A Journal of Medical Humanities. https://hekint.org/2018/09/18/pellagra-a-medical-whodunit/ Jaworek, Andrzej K. et al. “The history of pellagra.” Dermatol Rev/Przegl Dermatol 2021, 108, 554–566 DOI: https://doi.org/10.5114/dr.2021.114610 Kean, Sam. “Joseph Goldberger’s Filth Parties.” Science History Institute Museum and Library. https://www.sciencehistory.org/stories/magazine/joseph-goldbergers-filth-parties/ Kiple, Kenneth F. and Virginia H. “Black Tongue and Black Men: Pellagra and Slavery in the Antebellum South.” The Journal of Southern History , Aug., 1977, Vol. 43, No. 3. https://www.jstor.org/stable/2207649 Kraut, Alan. “Dr. Joseph Goldberger & the War on Pellagra.” National Institutes of Health Office of NIH History and Stetten Museum. https://history.nih.gov/pages/viewpage.action?pageId=8883184 Marks, Harry M. “Epidemiologists Explain Pellagra: Gender, Race and Political Economy in the Work of Edgar Sydenstricker.” Journal of the History of Medicine and Allied Sciences , JANUARY 2003. https://www.jstor.org/stable/24623836 Morabia, Alfredo. “Joseph Goldberger’s research on the prevention of pellagra.” J R Soc Med 2008: 101: 566–568. DOI 10.1258/jrsm.2008.08k010. Park, Youngmee K. et al. “Effectiveness of Food Fortification in the United States: The Case of Pellagra.” American Journal of Public Health. May 2U(H). Vol. 90. No. 5. Peres, Tanya M. “Malnourished.” Gravy. Southern Foodways Alliance. Fall 2016. https://www.southernfoodways.org/malnourished-cultural-ignorance-paved-the-way-for-pellagra/ Pinheiro, Hugo et al. “Hidden Hunger: A Pellagra Case Report.” Cureus vol. 13,4 e14682. 25 Apr. 2021, doi:10.7759/cureus.14682 A. C. Wollenberg. “Pellagra in Italy.” Public Health Reports (1896-1970), vol. 24, no. 30, 1909, pp. 1051–54. JSTOR, https://doi.org/10.2307/4563397. Accessed 13 Feb. 2025. Rajakumar, Kumaravel. “Pellagra in the United States: A Historical Perspective.” SOUTHERN MEDICAL JOURNAL • Vol. 93, No. 3. March 2020. Savvidou, Savvoula. “Pellagra: a non-eradicated old disease.” Clinics and practice vol. 4,1 637. 28 Apr. 2014, doi:10.4081/cp.2014.637 SEARCY GH. AN EPIDEMIC OF ACUTE PELLAGRA. JAMA. 1907;XLIX(1):37–38. doi:10.1001/jama.1907.25320010037002j Skelton, John. “Poverty or Privies? The Pellagra Controversy in America.” Fairmount Folio: Journal of History. Vol. 15 (2014). https://journals.wichita.edu/index.php/ff/article/view/151 Tharian, Bindu. "Pellagra." New Georgia Encyclopedia, 20 September 2004, https://www.georgiaencyclopedia.org/articles/science-medicine/pellagra/. University Libraries, University of South Carolina. “A Gospel of Health: Hilla Sheriff's Crusade Against Malnutrition in South Carolina.” https://digital.library.sc.edu/exhibits/hillasheriff/history-of-pellagra/ University of Alabama at Birmingham. “Pellagra in Alabama.” https://library.uab.edu/locations/reynolds/collections/regional-history/pellagra Wheeler, G.A. “A Note on the History of Pellagra in the United States.” Public Health Reports (1896-1970) , Sep. 18, 1931, Vol. 46, No. 38. Via JSTOR. https://www.jstor.org/stable/4580180 See omnystudio.com/listener for privacy information.

Jason Rantz, host of The Jason Rantz Show on KTTH 770AM/94.5 FM in Seattle/Tacoma and author of What's Killing America, joined the Guy Benson Show today to discuss Macklemore's anti-American and anti-Semitic comments at a Seattle concert. Jason also discussed his eye-opening experience gathering “harm reduction” kits in Seattle, where he shockingly received drug paraphernalia like a crack pipe. Listen to the full interview below! Learn more about your ad choices. Visit megaphone.fm/adchoices

Fourteen Marylanders have died of heat-related causes this year. As climate change drives up the intensity and duration of heat waves, what can public officials do? Hopkins epidemiologist Jaime Madrigano offers insight and solutions.Links:Maryland Department of Health Office of Preparedness and Response579 - How to Be a Climate Change Advocate: Making Sure Public Health is Part of the Climate Change EquationClimate Change Indicators: Heat Waves | US EPADo you have a question or comment about a show or a story idea to pitch? Contact On the Record at: Senior Supervising Producer, Maureen Harvie she/her/hers mharvie@wypr.org 410-235-1903 Senior Producer, Melissa Gerr she/her/hers mgerr@wypr.org 410-235-1157 Producer Sam Bermas-Dawes he/him/his sbdawes@wypr.org 410-235-1472

Multidrug-resistant organisms (MDROs) are a major concern for the nursing home population, who are at risk for developing severe infections. In today's webinar, we'll discuss an overview of MDROs in relation to long-term care.We're joined by Valerie Jividen, epidemiologist and lab-epi liaison for the West Virginia Department of Health Office of Epidemiology and Prevention Services. To contact Valerie Jividen, email Jividen, valerie.s.jividen@wv.gov.Watch RecordingDownload MDRO Outbreak ToolkitDownload Presentation SlidesCheck out our other interviews by visiting https://www.qualityinsights.org/ qin/multimedia This material was prepared by Quality Insights, a Quality Innovation Network - Quality Improvement Organization under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. Publication number 12SOW-QI-GEN-070424-CC-A

In 2023, the New York State Department of Transportation experienced 214 work zone traffic intrusions. The majority of these crashes were caused by distracted driving, following too closely, unsafe lane change, or disregarding traffic warning signs. Workers' Memorial Day takes place on April 28 and is a chance to remember the many highway and transportation workers who have made the ultimate sacrifice in service to the public. On this episode of the DOT POD, Josh and Anya are joined by two people who know just how dangerous these work zones can be when drivers don't do their part to keep the roads safe, Karen Torres and Cody Baker. Karen lost her father, Patrick Mapleson, to a distracted driver who entered his DOT work zone. She shares her family's story and how she transformed her grief into a mission as a safety advocate. Cody is with DOT's Main Office Employee Safety and Health Office and talks about our annual Workers Memorial event. We want to thank all of our dedicated and hard working DOT highway workers who put their own safety on the line so that we can get to our destinations safe. And we ask motorists to slow down, move over, and pay attention!

In this episode, we will review C. auris' definition and background; review infection prevention and control guidance; describe the screening process; and more. We're joined by Valerie Jividen, epidemiologist and lab-epi liaison for the West Virginia Department of Health Office of Epidemiology and Prevention Services. To contact Valerie Jividen, email Jividen, valerie.s.jividen@wv.gov.Watch RecordingDownload Presentation SlidesCheck out our other interviews by visiting https://www.qualityinsights.org/qin/multimedia This material was prepared by Quality Insights, a Quality Innovation Network - Quality Improvement Organization under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. Publication number 12SOW-QI-GEN-040424-CC-A 

Do those supplements have the benefits you think they do? This episode addresses five of the more popular selling supplements, what they do, and whether they are worth the investment to take them. Discover the ins and outs of Vitamin D, Fish Oil, Multivitamins, Probiotics, and Vitamin C. Uncover their proven benefits, potential risks, and whether they're worth considering for your health journey. Read more: Navigating the Supplement Aisle: Understanding the Pros and Cons of Five Popular Dietary Supplements   Read more: National Institutes of Health Office of Dietary Supplements Dietary Supplement Fact Sheets.   Listen: Real World Nutrition Episode 123: The Truth About Supplements   Read more: Navigating the Supplement Maze: Unveiling the Truth and Myths Schedule a free 30-minute introductory call today to learn how I can help you reach your health and wellness goals. Enroll in the Mini Course: 6 Tips for the Busy Person to Have Sustainable Energy: All-Day Energy Through Food AND Companion Workbook

In this episode, join Logan and Saman as they engage in a profound conversation with Dr. Mitchell, delving into the world of addiction medicine. The trio explores the vital concept of harm reduction, sheds light on Suboxone therapy, and reflects on Dr. Mitchell's firsthand experiences with patients battling substance use disorders.For a deeper understanding of harm reduction, visit the National Harm Reduction Coalition's website: https://harmreduction.org/about-us/principles-of-harm-reduction/Discover the world of addiction medicine through the lens of Gabor Maté in his compelling book, "In the Realm of Hungry Ghosts: Close Encounters with Addiction."Connect with WCUCOM's Addiction Medicine Interest Group on Instagram: @wcucom.amig. Don't miss their upcoming events, including "Research Topics in Addiction Medicine" on December 3rd at 4pm via Teams and the Xylazine Information Forum.Explore valuable resources in Mississippi, such as the MS Department of Health Office of Substance Use Disorders: https://msdh.ms.gov/page/44,25061,382,61.html.Additionally, make a difference by supporting "Make MS OD Free," offering free Naloxone for Mississippi residents: https://odfree.org/get-naloxone/.For nationwide initiatives, check out EndOverdose (https://endoverdose.net/), a crucial resource in the collective effort against addiction.You can leave any comments, feedback, or suggestions for us through this form. https://forms.office.com/r/Hw127ACAuq

Mentioned in this Episode: National Institutes of Health- Office of Research for the Health of Womenhttps://orwh.od.nih.gov/toolkit/nih-policies-inclusion/guidelines World Health Organization- Women's Health- https://www.who.int/health-topics/women-s-health Dr. Lerner's Bloghttp://www.umalernermd.com/blog  For more on Dr. Uma Lerner you can follow her on Instagram @drumalerner and through her website http://www.umalernermd.com/. For more on Argavan Nilforoush, be sure to follow her on Instagram @babystepsnutrition, on Facebook: Baby Steps Nutrition page, on YouTube: Baby Steps Nutrition Podcast, on Twitter @argavanRDN, on LinkedIn @ArgavanNilforoush and through her website www.babystepsnutrition.com. 

This week we had such a great conversation with Laura Manning, MPH, RDN, CDN! Laura is a registered dietitian that works with the IBD team at the Susan and Leonard Feinstein Inflammatory Bowel Disease Center at Mount Sinai Medical Center. We talked to her about her interesting and unique career before she became a dietitian and why she switched. We talked about nutrition therapy for people living with Crohn's disease and her research on scurvy and IBD. We discussed nutritional supplements and their safety and also how to introduce foods back into  your diet. We also discussed the very effective and empowering GRITT-IBD program which is a multi-disciplinary program intended to provide services and support that will help patients have improved quality of life. Finally we talked about fish. We loved our conversation and laughs with Laura this week and we know you will too! Please keep in mind that the views and opinions expressed in this program are those of the speakers and should not be considered medical advice. Please consult with your healthcare team on any changes to your disease, diet, or treatment. We want you to stay safe and healthy! ;) Links: Information about the GRITT-IBD Program- Mount Sinai IBD CenterAn article on Scurvy and IBD that talks about Mt. Sinai's findings- General Surgery NewsLaura and the Mt. Sinai team's Journal article- Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient- Crohn's & Colitis 360Dietary Supplements: What You Need to Know- US National Institutes of Health Office of Dietary SupplementsLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

In episode 8, Dr. Mark Hoffman invites Drs. Melissa Wong of Cedars-Sinai and Tony Shanks of Indiana University to share the mic and talk about the use of virtual reality (VR) in labor. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/StyzOA --- SHOW NOTES Dr. Melissa Wong, MD, MHDS is a board-certified Maternal Fetal Medicine specialist and an Assistant Professor of OB/GYN at Cedars-Sinai in Los Angeles, California. She also works in the division of informatics and with the National Institutes of Health Office of Research on Women's Health. Dr. Wong has studied the use of VR to mitigate the pain associated with labor, and she is continually finding opportunities for the use of VR to enhance the field of OB/GYN. Dr. Tony Shanks, MD, a co-host of BackTable OBGYN, joins the podcast again as a Maternal Fetal Medicine specialist at Indiana University. He currently serves as the Vice Chair of Education at the institution, as well as the Maternal Fetal Medicine Fellowship Director. In this episode, Dr. Wong describes the methods and conclusions of her study, “Virtual Reality Reduces Pain in Laboring Women: A Randomized Controlled Trial,” which ultimately determined that the use of VR was associated with a reduction in pain during labor compared to patients who received no intervention. The group also discusses the potential for VR within the obstetrical and gynecologic sides of the field, as well as the field of medicine in general. Some topics that were mentioned include the use of VR for in-office procedures and patient education through visualization of complicated surgical procedures. In addition, the group highlights the potential for additional technological advancements in medicine through augmented reality, artificial intelligence, and informatics. --- RESOURCES Wong MS, Spiegel BMR, Gregory KD. Virtual Reality Reduces Pain in Laboring Women: A Randomized Controlled Trial. Am J Perinatol. 2021 Aug;38(S 01):e167-e172. doi: 10.1055/s-0040-1708851. Epub 2020 Jun 2. PMID: 32485759. Sridhar A, Shiliang Z, Woodson R, Kwan L. Non-pharmacological anxiety reduction with immersive virtual reality for first-trimester dilation and curettage: a pilot study. Eur J Contracept Reprod Health Care. 2020 Dec;25(6):480-483. doi: 10.1080/13625187.2020.1836146. PMID: 33140989. “Rewiring Education” by John D. Couch “Deep Medicine” by Eric Topol “Measure What Matters” by John Doerr

Kachina Chawla from USAID joins Ann to discuss her work in India. Kachina and her colleagues work to prevent and treat Tuberculosis, HIV, and other diseases that otherwise might not be provided for in many communities. Communities are the "epicenter" of this work.  Working within communities helps her team reach out to the most marginalized. Kachina offers specific examples as to why drugs alone will not improve health. Kachina educates us on what USAID is, who funds it, and explains her role in the organization as well as her personal outlook on working in communities. Her specific examples will help you think about how you can be more effective in your community work.Items discussed :Why communities are the critical branch of the health systemHow communities provide the feedback needed to bridge the demand and supply gapWhy she chose the Empowerment Methodology and the power of community dialogueThe role of the government in health promotionWe need to let go of our own baggage when working in and with communitiesWhy the power of the collective is the community possibility she seesBioKachina Chawla, MPH, is the Senior Advisor for the Health Office at USAID/India where she works on digital technology, inclusive development and other emerging priorities such as COVID-19, air pollution and urban resilience. She is a public health professional who has spent the last 20 years working extensively in areas of maternal and child health, family planning and infectious diseases across three continents. Prior to joining USAID, Kachina was a founding partner at Lighthouse Health Solutions LLC, an international consulting firm that serviced clients like BMGF, the Packard Foundation and the Public Health Institute. At Lighthouse, she led their investment on using social movements to ignite changes that impact health.  Kachina received her bachelor's degree in History and Science from Bennington College, Vermont, and a master's degree in Public Health, specializing in Monitoring and Evaluation from the School of Public Health and Tropical Medicine at Tulane University, New Orleans.Community Possibilities is produced by Zach PriceMusic by Zach PriceLike what you heard? Please like and share wherever you get your podcasts! Connect with Ann: Community Evaluation Solutions How Ann can help: · Support the evaluation capacity of your coalition or community-based organization. · Help you create a strategic plan that doesn't stress you and your group out, doesn't take all year to design, and is actionable. · Engage your group in equitable discussions about difficult conversations. · Facilitate a workshop to plan for action and get your group moving. · Create a workshop that energizes and excites your group for action. · Speak at your conference or event. Have a question or want to know more? Book a call with Ann .Be sure and check out our updated resource page! Let us know what was helpful. Community Possibilities is Produced by Zach Price Music by Zach Price: Zachpricet@gmail.com

In this week's episode of Ask Me Anything, Mike answers your questions on how much chicken a gorilla eats, how to improve the health of your business, when is it the right to get an office, and whether you should pay commission-only salespeople through a W-2 or 1099.

Vitamin and mineral supplements are the most commonly used dietary supplements by populations worldwide. They are called supplements because that is the intention: to fill in nutritional gaps in your diet, not to make up for a bad diet.No supplement replaces a healthy plant forward diet but what should you take to help make sure you are getting all the nutrients you need for good health? The aisles are full of vitamins, minerals and all kinds of supplements – in all kinds of forms – promising all kinds of benefits.Today we interview nutrient researcher Dr Jeffry Blumberg, Professor Emeritus in the Friedman School of Nutrition Science at Tufts University. He unpacks the real evidence on supplements to help you personalize what you should take.Key Messages on the Facts about Vitamin and Mineral Supplements:Children, young women, older adults, vegetarians, and vegans are at the greatest risk of several deficiencies.A diet rich in whole, nutrient-dense foods is the best way to prevent deficiency.Taking more than the recommended dose could result in toxicity.Consult your physician if you suspect you have a nutrient deficiency and to check if your medications could interfere with nutrient absorption.Form doesn't matter (eg pill vs gummy vs liquid). What matters is to take your supplements regularly.Supplements do not prevent chronic disease.Supplements lack standardization so one multivitamin can be very different from another.ResourcesCenter for Science and Public InterestNational Institutes of Health Office of Dietary Supplements Linus Pawling Institute at Oregon State University Your physician, registered dietician and pharmacist

Choline is all the rage right now and is touted as a super nutrient for fetal brain development, cognitive function, and reducing the risk of neural tube defect (NTD).   However, is choline needed to help you get pregnant?  In this episode, I answer the question by examining the facts and evidence on choline.   References: Boeke, C. E., Gillman, M. W., Hughes, M. D., Rifas-Shiman, S. L., Villamor, E., & Oken, E. (2013). Choline intake during pregnancy and child cognition at age 7 years. American journal of epidemiology, 177(12), 1338–1347. https://doi.org/10.1093/aje/kws395 Choline. (2021, March 29). National Insitute of Health: Office of Dietary Supplements. Retrieved March 2, 2022, from https://ods.od.nih.gov/factsheets/Choline-HealthProfessional/ Korsmo, H. W., Jiang, X., & Caudill, M. A. (2019). Choline: Exploring the growing science on its benefits for moms and babies. Nutrients, 11(8), 1823. https://doi.org/10.3390/nu11081823 Irvine, N., England-Mason, G., Field, C. J., Dewey, D., & Aghajafari, F. (2022). Prenatal folate and choline levels and brain and cognitive development in children: A critical narrative review. Nutrients, 14(2), 364. https://doi.org/10.3390/nu14020364

Dr. Parham Jaberi, Chief Deputy Commissioner, Community Health ServicesDr. Parham Jaberi is a board-certified Preventive Medicine physician serving as the Assistant Secretary for the Louisiana Department of Health Office of Public Health. In this role, Dr. Jaberi provides oversight to over 1200 employees providing services in over 60 programs focused on clinical and preventative services, health promotion, environmental health services, and other services such as vital records. In addition, Dr. Jaberi serves as the Assistant State Health Officer providing support to the agency's efforts in emergency response to weather-related events, infectious disease outbreaks, or other public health threats, He is the local Health Director of the Norfolk, for this episode of We Are Living Healthy with Alexis, and Dr Jaberi will talk about Covid 19.Key Takeaways from Alexis chat with Dr Jaberi:-Where are we now with Covid 19?-VDH is working to inform people about vaccination. Where can they go to find out this information locally here in Virginia and or out state??-When it comes to the Holidays, are there any updates on how to stay safe while you gather with your loved ones?-Can you tell us more about the new booster vaccines and the vaccine for children ages 5-11 years old?-What are Covid 19 Boosters?For more information go to: vdh.virginia.comFor more great We Are Living Healthy content, don't forget to subscribe to the podcast on all major podcasting platforms. https://livinghealthy.buzzsprout.comAlready subscribed? Please take a moment to rate and review the podcast so that we can reach as many people that need the help as we can: https://3cstvshow.buzzsprout.com Follow us on Facebook: @WeAreLivingHealthyTVDISCLAIMER: THE CONSULTATIONS OR INTERACTIONS OFFERED ARE NOT MEANT TO REPLACE A CONSULTATION WITH YOUR PHYSICIAN. THE CONSULTATION IS FOR EDUCATIONAL PURPOSES ONLY AND NOT STRUCTURED IN A WAY TO PROVIDE HEALTH COUNSELING / DIAGNOSING OF ANY KIND. YOU UNDERSTAND THAT WE ARE LIVING HEALTHY IS NOT PROVIDING INFORMATION AS YOUR TREATING HEALTH COUNSELOR, PHYSICIAN, ATTORNEY, LEGAL COUNSEL, EMPLOYER, MEDICAL PROFESSIONAL. We offer no guarantees or promise of results from event nor assume liability for any information provided. 

Join Paige as she talks with Professor Tan Chorh Chuan, the first Chief Scientist at the Ministry of Health, as well as executive director of the Ministry of Health Office for Healthcare Transformation. He led Singapore in combating SARS, now serves as one of the top strategists in our ongoing battle against Covid-19, and was president of NUS for a decade. Their discussion covers crisis leadership, health care capacity, Singapore's risk-based approach to easing restrictions, and the needed protocols to ensure a safe Vaccinated Travel Lane future. Chorh Chuan reflects on his early passion to study medicine, and ultimately to work in medical academia. He shares his thoughts on effective leadership, habits to fuel success, and how we all need a mindset of optimism to drive change, which should be combined with constructive dissatisfaction. And he's all for lessening social media: “It could fill every minute of your waking time. We must leave enough time to engage with the real world.” Listen and share this informative and thoughtful episode, so together we may Pass the Power! Follow Paige Parker on Instagram. Keep up to date with Paige Parker and MOH Office for Healthcare Transformation on LinkedIn. Thank you to Deity Mics and City Music SG for providing me with the equipment I use to record! Visit their page at: https://www.facebook.com/deitymicsasia https://www.facebook.com/citymusicsg https://www.facebook.com/zoomsoundlab

Upward of 30% of people diagnosed with Covid-19 will develop the postacute syndrome referred to as long Covid. In this interview, listeners will find out more information about long Covid and also discover how homeopathy may be able to help these patients. Jennifer Jacobs, MD, MPH, from the University of Washington, and Elizabeth Rice, ND, from the Southwest College of Naturopathic Medicine will describe their upcoming study and recruiting criteria for participants. To find out more about the study, visit www.longhaulstudy.com. About the Experts Jennifer Jacobs, MD, MPH, is a family practice physician specializing in homeopathic medicine. She is also a clinical assistant professor in epidemiology at the University of Washington. She received her MD degree from Wayne State University and a masters in public health from the University of Washington. She has served on the advisory board of the National Institutes of Health Office of Alternative Medicine and has published numerous homeopathic research studies in peer-reviewed medical journals. She is also the coauthor of Healing with Homeopathy, and the author of Do You Really Need That Pill?, which takes on the growing epidemic of overmedication. Elizabeth Rice, ND, received her doctorate in naturopathic medicine in 2009 from Southwest College of Naturopathic Medicine (SCNM). In 2002, she received her bachelor of arts degree in both Spanish and global studies from the University of California at Santa Barbara. Following graduation from SCNM, Rice completed a first-year residency focused on primary care family medicine and a second-year specialty residency focused in classical Hahnemannian homeopathy. Rice is currently an assistant professor and interim department chair of homeopathy and pharmacology at the Southwest College of Naturopathic Medicine. Additionally, she has a family medicine private practice specializing in the homeopathic treatment of depression and anxiety.

Deputy Prime Minister Chrystia Freeland makes an announcement and responds to questions from reporters in Hamilton, Ontario. Federal ministers François-Philippe Champagne (industry) and Filomena Tassi (labour) also take part in the announcement.

In June 2019, Carin Morrell joined the University of Maryland, Baltimore (UMB) as the first Public Information Officer (PIO) for the Police Department and Office of Emergency Management. As PIO, she's a social media manager, photographer, videographer, graphic designer, speechwriter, website developer, and crisis communicator. She manages media inquiries, community complaints, and all public-facing messaging for a police department of 200+ men and women (plus one dog), as well as UMB's newest department, the Office of Emergency Management.  Prior to joining UMB, Morrell spent three years as PIO for the Maryland Department of Health Office of Preparedness and Response, where she managed all public-facing communications related to public health emergencies for the State of Maryland. In 2019, she was selected to present a social media accessibility poster at the National Preparedness Summit. She was recognized by Governor Hogan's Office of Communications for social media management and routinely ran the Maryland Emergency Management Agency Joint Information Center during graded statewide and national exercises. Morrell has also served as communications coordinator for the Peabody Institute of The Johns Hopkins University and spent years producing newscasts at WBAL-TV and WISC-TV. Morrell taught news reporting at Loyola University Maryland, led nationwide social media campaigns, spearheaded departmental website redesigns, and developed branding and marketing strategies for state political campaigns. She earned a master's degree from the University of Wisconsin-Madison School of Journalism and Mass Communication in 2012 and is currently earning a second master's degree in strategic communications from the University of Maryland Global Campus.Carin's Linked in link Support the show (https://t.co/GOmAg9X6e8?amp=1)

Flathead City County Health Office Joe Russell appeared on the KGEZ Good Morning Show with John Hendricks and Robin Mitchell on Friday May 21, 2021 for a weekly COVID-19 update.

Get to know me as we take this journey together. My name is Marquita LaGarde I am a licensed clinical therapist and I will take this time to discuss topics surrounding mental health and joining with other professionals to break down barriers surrounding the health professions. Welcome. You can find me on IG @BLKMHC

Click to listen to episode (4:42) Sections below are the following:Transcript of AudioAudio Notes and AcknowledgmentsImageSources for More InformationRelated Water Radio EpisodesFor Virginia Teachers (Relevant SOLs, etc.) Unless otherwise noted, all Web addresses mentioned were functional as of 2-12-21. TRANSCRIPT OF AUDIO From the Cumberland Gap to the Atlantic Ocean, this is Virginia Water Radio for the week of February 15, 2021. SOUND - ~7 sec – Pouring water then ice cubes This week, we focus on drinking water and Virginia Tech research on customers’ trust of their local water supply system.  Our guest voice this week is Maddy Grupper, a recent master’s graduate from the Virginia Tech Department of Forest Resources and Environmental Conservation.  We start with a 40-second except of a talk Maddy gave on her research at the Nutshell Games, conducted by the Virginia Tech Center for Communicating Science. VOICE - 38 sec – Nutshell Games excerpt:“It’s 2014, you live in Toledo, OH…Thick green algae has invaded Lake Erie, your water source, and for days you can’t fill up your water from the faucet and drink. What if we could prevent this? What if we could predict when water is going to go bad the same way a weatherman predicts a tornado…  We’re developing this technology…  But successful technology isn’t just the ones that work, it’s what the public trusts, accepts, and uses.  I study what factors impact that trust.” GUEST VOICE Hello, I’m Maddy Grupper, speaking to you now in 2021.  As you heard in that excerpt, I study people’s trust in the quality and safety of their drinking water. The quality of lakes, reservoirs, and other sources that humans use for drinking water can be affected by climate change, infrastructure degradation, and pollutants. Researchers are looking for innovative methods to maintain drinking water quality, such as technology to forecast threats like algae blooms and metal increases. But without trust, people might not support such new technologies or other changes. That can slow the ability of utilities to stay ahead of fast-acting threats.  The focus of my Virginia Tech master’s study was on the trust that community members have, or don’t have, in their utility.  In the fall of 2019 we surveyed over 600 customers of the water utility serving the Roanoke Valley of Virginia.  We found that 61% of the respondents mostly or completely trusted their utility to deliver safe drinking water to them. What is the basis of such trust?  Our study found evidence supporting a framework that claims a person’s trust is based on four sources:  1. Rational – that is, I trust you because I think you’re capable and have a good track record. 2. Affinitive – that is, I trust you because I like you, think you share my values, and have my best interests at heart. 3. Dispositional – that is, I trust you because I’m a trusting person. And 4. Procedural – that is, I trust the system that regulates you. Our study in the Roanoke Valley showed that as each of these factors increased, so did trust.  But we also found that high trust didn’t rely on just one or two of these factors; it needed all four. If water managers want to increase community support through trust, they need to take all four factors into account.  Understanding these trust factors might help water managers build more resilient systems. For community members, such understanding might give them a greater sense of control and peace of mind about what they drink. So, the next time you take a sip of water ask yourself, why do you, or don’t you, trust what you are drinking? END GUEST VOICE Thanks to Maddy Grupper for lending her voice and expertise to this episode. SHIP’S BELL Virginia Water Radio is produced by the Virginia Water Resources Research Center, part of Virginia Tech’s College of Natural Resources and Environment.  For more Virginia water sounds, music, or information, visit us online at virginiawaterradio.org, or call the Water Center at (540) 231-5624.  Thanks to Stewart Scales for his banjo version of Cripple Creek to open and close this show.  In Blacksburg, I’m Alan Raflo, thanking you for listening, and wishing you health, wisdom, and good water. AUDIO NOTES AND ACKNOWLEDGEMENTS Virginia Water Radio’s guest voice this week was Madeline (Maddy) Grupper, an August 2020 graduate of the Virginia Tech Department of Forest Resources and Environmental Conservation. The opening excerpt heard in this episode was from Maddy’s presentation at the October 27, 2018, Nutshell Games, conducted by the Virginia Tech Center for Communicating Science.  Maddy’s presentation was one of three top-honors winners at the event, where graduate students take 90 seconds to present their research and highlight its importance.  More information about the October 2018 event is available online at https://vtnews.vt.edu/articles/2018/11/2018-nutshell-game-winners.html.  More information about the Center for Communicating Science is available online at https://communicatingscience.isce.vt.edu/. A 2020 report on Maddy’s research is available online at https://vtechworks.lib.vt.edu/handle/10919/100105. The water utility participating in Maddy’s research was the Western Virginia Water Authority, serving customers in the City of Roanoke and the counties of Botetourt, Franklin, and Roanoke.  More information about that utility is available online at https://www.westernvawater.org/. Click here if you’d like to hear the full version (1 min./11 sec.) of the “Cripple Creek” arrangement/performance by Stewart Scales that opens and closes this episode.  More information about Mr. Scales and the group New Standard, with which Mr. Scales plays, is available online at http://newstandardbluegrass.com. IMAGE Maddy Grupper during her survey in 2019 of trust in drinking water among utility customers in Virginia’s Roanoke Valley area.  Photo courtesy of Maddy Grupper. SOURCES OFFERING MORE INFORMATION ON DRINKING WATER U.S. Centers for Disease Control and Prevention (CDC), “Drinking Water,” online at https://www.cdc.gov/healthywater/drinking/index.html. U.S. Environmental Protection Agency (EPA), “Ground Water and Drinking Water,” online at https://www.epa.gov/ground-water-and-drinking-water. U.S. Geological Survey (USGS), “Drinking Water and Sources Water Research,” online at https://www.usgs.gov/mission-areas/water-resources/science/drinking-water-and-source-water-research?qt-science_center_objects=0#qt-science_center_objects. Virginia Department of Health/Office of Drinking Water, online at https://www.vdh.virginia.gov/drinking-water/. Virginia Cooperative Extension/Virginia Household Water Quality Program, online at https://www.wellwater.bse.vt.edu/vahwqp.php. RELATED VIRGINIA WATER RADIO EPISODES All Water Radio episodes are listed by category at the Index link above (http://www.virginiawaterradio.org/p/index.html).  See particularly the “Overall Importance of Water” and “Science” subject categories. Following are links to some other episodes on drinking water or water sources. Drinking Water Week – Episode 314, 5-2-16.SERCAP (Southeast Regional Community Assistance Project) work on rural water needs – Episode 366, 5-1-17. Virginia Household Water Quality Program – Episode 361, 3-27-17.Worldwide water needs – Episode 122, 8-6-12. Following are links to some other episodes on research by Virginia university students, including research presented the Nutshell Games, conducted by the Virginia Tech Center for Communicating Science. On antibiotic resistance – Episode 290, 11-16-15.On avian malaria – Episode 259, 3-30-15.On the Emerald Ash Borer – Episode 376, 7-10-17 (based on a Nutshell Games presentation).On headwater streams – Episode 397, 12-4-17 (based on a Nutshell Games presentation).On oysters and nitrogen – Episode 280, 9-7-15On soils and greenhouse gases – Episode 312, 4-18-16.On streams buried under human infrastructure – Episode 409, 2-26-18 (based on a Nutshell Games presentation). FOR VIRGINIA TEACHERS – RELATED STANDARDS OF LEARNING (SOLs) AND OTHER INFORMATION Following are some Virginia Standards of Learning (SOLs) that may be supported by this episode’s audio/transcript, sources, or other information included in this post. 2018 Science SOLs Grades K-5: Earth Resources 3.8 – Natural events and humans influence ecosystems. 4.8. – Virginia has important natural resources. Grade 6 6.6 – Water has unique physical properties and has a role in the natural and human-made environment. 6.8 – Land and water have roles in watershed systems. 6.9 – Humans impact the environment and individuals can influence public policy decisions related to energy and the environment. Earth Science ES.6 – Resource use is complex. ES.8 – Freshwater resources influence and are influenced by geologic processes and human activity. 2015 Social Studies SOLs Civics and Economics Course CE.8 – government at the local level. CE.10 – public policy at local, state, and national levels. World Geography Course WG.2 – how selected physical and ecological processes shape the Earth’s surface, including climate, weather, and how humans influence their environment and are influenced by it. Virginia and United States History Course VUS.14 – political and social conditions in the 21st Century. Government Course GOVT.1 – skills for historical thinking, geographical analysis, economic decision-making, and responsible citizenship. GOVT.8 – state and local government organization and powers. GOVT.9 – public policy process at local, state, and national levels. GOVT.15 – role of government in Va. and U.S. economies, including examining environmental issues and property rights. Virginia’s SOLs are available from the Virginia Department of Education, online at http://www.doe.virginia.gov/testing/. Following are links to Water Radio episodes (various topics) designed especially for certain K-12 grade levels. Episode 250, 1-26-15 – on boiling, for kindergarten through 3rd grade. Episode 255, 3-2-15 – on density, for 5th and 6th grade. Episode 282, 9-21-15 – on living vs. non-living, for kindergarten. Episode 309, 3-28-16 – on temperature regulation in animals, for kindergarten through 12thgrade. Episode 333, 9-12-16 – on dissolved gases, especially dissolved oxygen in aquatic habitats, for 5th grade. Episode 403, 1-15-18 – on freezing and ice, for kindergarten through 3rd grade. Episode 404, 1-22-18 – on ice on ponds and lakes, for 4th through 8thgrade. Episode 406, 2-5-18 – on ice on rivers, for middle school. Episode 407, 2-12-18 – on snow chemistry and physics, for high school. Episode 483, 7-29-19 – on buoyancy and drag, for middle school and high school. Episode 524, 5-11-20 – on sounds by water-related animals, for elementary school through high school. Episode 531, 6-29-20 – on various ways that animals get water, for 3rdand 4th grade. Episode 539, 8-24-20 – on basic numbers and facts about Virginia’s water resources, for 4th and 6th grade.

Jeanne talks with March of Dimes' Senior Vice President and Chief Medical and Health Office, Dr. Rahul Gupta, about the March of Dimes focus on women to improve women's and babies' health. Learn more about your ad choices. Visit megaphone.fm/adchoices

Please join us to hear from Public Health Officer Dr. Mark Larson! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

NASN School Nurse Editor, Cynthia Galemore, interviews author Eileen Moss about the article, "Enhancing Your Virtual Footprint: The School Nurse’s Professional Health Office Website". To view the article, click here.

A group of our Franklin Public School nurses share important information related to Health Office procedures, guidelines, and COVID-19 testing. Topics covered include: FPS Dismissal Procedures Reporting of Absences COVID-19 Testing and Timelines Travel Information Over the Counter Medicine Where to find information! Thank you to Franklin TV & Radio for their assistance in creating this podcast!

Podcast Guest: Teri Fritsma, Senior Research Analyst, Minnesota Department of Health - Office of Rural Health & Primary Care Podcast Host: Nitika Moibi, Health Workforce Analysis Supervisor, Minnesota Department of Health - Office of Rural Health & Primary Care View details of the entire podcast series at https://minnesotaruralhealthconference.org/podcasts! Nitika Moibi and Teri Fritsma will discuss the rapid transformation that COVID has brought to the health care workforce in Minnesota - reduced hours, layoffs, and even rural retirements in certain sectors of health care. On the other hand, COVID has also caused the swift expansion of telemedicine—a likely permanent change that could improve Minnesotans’ access to care now and well into the future. Hear what health care providers say are their greatest concerns during this period. This series was developed by the Minnesota Rural Health Conference hosts – the Minnesota Department of Health’s (MDH) Office of Rural Health and Primary Care (ORHPC), the National Rural Health Resource Center, and the Minnesota Rural Health Association (MRHA).

Podcast Guest: Jan Malcolm, Commissioner, Minnesota Department of Health Podcast Host: Zora Radosevich, Director, Minnesota Department of Health - Office of Rural Health & Primary Care View details of the entire podcast series at https://minnesotaruralhealthconference.org/podcasts! The ORHPC's Director will have a discussion with the Commissioner about why rural health issues deserve special attention, how the Minnesota Department of Health supports health care professionals in rural areas, and what some of the important issues are in addressing the pandemic and its impact on rural MN. This series was developed by the Minnesota Rural Health Conference hosts – the Minnesota Department of Health’s (MDH) Office of Rural Health and Primary Care (ORHPC), the National Rural Health Resource Center, and the Minnesota Rural Health Association (MRHA).

CBD and cannabis testing with Roger Brown, CEO/ President of ACS Laboratory. Our next guest is the president of the largest hemp, CBD, and cannabis testing facility in the Eastern United States. It is one of the largest and top-ranking laboratories for precision testing of hemp, CBD, and cannabis in the U.S. with customers in 44 states throughout the country. ACS Laboratory recently acquired Botanica Testing Inc., certified hemp and CBD testing laboratory thus expanding your position as the largest and the Most Trusted Cannabis and Hemp Laboratory in the USA. ACS Laboratory recently announced the Florida Department of Health Office of Medical Marijuana Use (OMMU) has certified ACS to test products for medical dispensaries in the state. This certification comes after the Florida Department of Health adopted an emergency rule, requiring dispensaries to only use a certified lab for product testing. Dispensaries (or medical marijuana treatment centers as the state calls them) in Florida have until December 24, 2020, to sell products tested before June 24, 2020. The Florida rules mandate that labs are ISO-accredited and qualified to accurately test for contaminants, moisture content, and cannabinoid potency. We dive into what kind of impact this will have on what you can do in the Florida Medical Marijuana market as well as much more!

COVID-19 update with Dr. Howard Leibrand Skagit County public health officer. He talks about the increasing numbers of infections deaths and how I see the ICUs are being overwhelmed. Free influenza shots for the uninsured are going to be available at the Skagit Valley College testing site.

Healthcare Superteams explores how to reinvent and reimagine team-based care with expert insight and best practices from interprofessional leaders and team scientists to transform the future of health. By leveraging our many collective strengths, we can provide the best outcomes and make life better for patients and communities. The future of health care depends not only on highly skilled and passionate providers and clinicians but also on their ability and willingness to collaborate across their professions. This transformation begins with one commitment: interprofessional education and practice. The idea that seamless communication and high-functioning teamwork between health care professionals will improve patient safety, patient and provider satisfaction, health outcomes, and reduce health costs. We don't need superpowers to transform health care. We need super healthcare teams. Healthcare Superteams is presented by the USF Health Office of Interprofessional Education and Practice and is hosted by its Assistant Vice President, Dr. Haru Okuda.

Johns Hopkins Bloomberg School of Public Health professor Keshia Pollack Porter and colleagues recently penned a Health Affairs blog calling for nonpartisan, objective analysis of legislation by a Congressional Health Office. The Office would evaluate and score legislation for intended and unintended impacts on health and equity, help educate policymakers, and advocate for “health in all policies.” Dr. Porter talks to Dr. Josh Sharfstein about how such a new office might work, and obstacles to its success.

Today, we are announcing 82 new cases, including one epi-linked case, for a total of 9,220 cases in British Columbia.“There are 1,261 active cases of COVID-19 in the province, 3,093 people who are under active public health monitoring as a result of identified exposure to known cases and 7,695 people who tested positive have recovered.

Food can be one of the many paths to healing. There are essential minerals that the body needs to function. Run low on them and you might have problems sleeping, focusing and functioning.   In this episode, a look at the mineral magnesium, what it can do for you and some of the foods and products you can access to get you up to proper levels.   If you need support contact the National Suicide Prevention Lifeline at 1-800-273-8255, the Trevor Project at 1-866-488-7386 or text “START” to 741-741. Resources Mentioned:  Inside of You Podcast with Michael Rosenbaum interview with Kevin Conroy   Game and On-Line Harassment Hotline website where you can get more information about the service.   National Institute of Health/Office of Dietary Supplements page on Magnesium, there is also a    Linus Pauling Institute Micronutrient Information Center page on Magnesium UCLA Explore Integrated Medicine page on  Stress-Reducing Foods, Herbal Supplements, and Teas UCI Health also has a page about foods that can reduce anxiety. Disclaimer:  Links to other sites are provided for information purposes only and do not constitute endorsements.  Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment.

Adrian Dix, Minister of Health, and Dr. Bonnie Henry, B.C.'s provincial health officer, have issued the following joint statement regarding updates on the novel coronavirus (COVID-19) response in British Columbia:

In Ottawa, Dr. Theresa Tam, Canada's chief public health officer, provides an update on the COVID-19 (coronavirus) pandemic.

Adrian Dix, Minister of Health, and Dr. Bonnie Henry, B.C.'s provincial health officer, have issued the following joint statement regarding updates on the novel coronavirus (COVID-19) response in British Columbia:

In Ottawa, Anita Anand, the minister of public services and procurement, and Dr. Howard Njoo, Canada's deputy chief public health officer, provide an update on the federal response to the COVID-19 (coronavirus) pandemic.

Follow me on Instagram Follow me on Facebook Research supplements here: Examine RxList National Institutes of Health: Office of Dietary Supplements Veggie capsules, the Capsule Machine, and herbs at Essential Organics Article from Global Essence : 5 Ways To Recognize if Your Essential Oils Are Fake 7 Reputable Essential Oils Companies (in no particular order) 1. Plant Therapy 2. Edens Garden 3. NOW Foods 4. Young Living 5. doTERRA 6. Rocky Mountain Oils 7. Mountain Rose Herbs

The COVID-19 pandemic has exposed like never before the perils of governments handing over our right to health and life to corporations. The privatisation of our health has made millions of people vulnerable to infectious diseases and undermined the integrated public systems needed to coordinate an effective response. This webinar brings healthcare experts together with activists at the forefront of struggles for equitable universal public healthcare from across the globe. Panelists speak about the changes that will be needed in terms of access to medicines, the pharmaceutical industry, healthcare systems, and the global governance of health. Organised by TNI and co-sponsored by AIDC, Focus on the Global South, Corporate Accountability International, People's Health Movement (PHM), Public Services International, Global Justice Now (GJN), RedLAM-Red Latinoamericana Acceso a Medicamentos, ABIA-Brazilian AIDS Interdisciplinary Association, and GTPI/Rebrip - Working Group on Intellectual Property. Panellists: • Susan George, President of the Transnational Institute and author of 'Shadow Sovereigns: How Global Corporations are Seizing Power' (2015). • Kajal Bhardwaj, health and human rights lawyer, India • Mark Heywood, Co-founder of Treatment Action Campaign, South Africa • Baba Aye, Health Office, Public Services International (PSI) • David Legge, People’s Health Movement representative

Hi, I'm Tom Rhodes, CEO of Spencer Health Solutions. Our podcast guest today is Joseph Kim, who is a member of the digital health office at Eli Lilly and the host of Lilly's podcast, The Elixir Factor. On our podcast, he talks about digital health innovation, the IBD challenge, sponsored by Eli Lilly, his podcast and cross-departmental drug development. We're proud to welcome a fellow podcaster to "People Always, Patients Sometimes". Janet Kennedy (00:34): Welcome to the "People Always, Patients Sometimes" podcast, a presentation of Spencer Health Solutions. Healthcare has come to a crossroads and it's time to start listening to new ideas that challenge our "always done it that way" thinking we hope you enjoy our conversations with the disruptors, the innovators and the transformers in clinical trials and healthcare. With me today is Joseph Kim from Eli Lilly. He has a title that's quite a mouthful. Senior advisor, digital health office, translational technology and innovation and we're going to talk about all of those things on the podcast today. Joe, welcome to the conversation. Joe Kim (01:12): It's great to be here. Janet, thanks for having me. I know it's been a little bit of a challenge to get our schedules to line up, but we're here now. Janet Kennedy (01:19): And I'm absolutely thrilled to have you here. We talk about you a lot over at the office because you are putting out a lot of great new ideas on your podcast, which we're going to talk about in a little bit and at events, conferences and trade shows. You're often a keynote or panelist member, but also imagine you're doing some pretty exciting things that Eli Lilly. You've certainly had a couple of changes in your title in the past few years, so things are very exciting where you are and I'd love for you to tell me a little bit about your history and how you got to Eli Lilly and then what you're doing now. Joe Kim (01:53): Yeah, sure. I mean I've only been at Lilly for about five and a half years, a little longer than that, which is a long time for me at any one company, but a very short time for anyone at Lilly. A lot of people who joined the company are there for 2030 35 years. So I'm still, despite for me, this being the longest role I've had at any one company, it's short time for others, so I still feel like the new kid on the block, but I joined their clinical innovation group when it was still in forest and that was run by Jeff Kasher who was the VP and well known in the industry. Still has, he hasn't faded into the background after leaving Lily, so he's still got his fingers in a number of pies helping other clinical research entrepreneurs and other pharma folks. I think I'm making sense of how to do things better. Janet Kennedy (02:41): Does that mean you have an intrepreneurial system going on at Eli Lilly where you are sort of embracing that spirit of entrepreneurship within the company? Joe Kim (02:50): Yes, but that's not really about how the company is set up, but there is plenty of room for people with that kind of ambition to develop new things and make the place better and better. Which is kind of a hallmark quote from our founder, which was to make Lilly a better and better place as you work here. So there's no like formal mechanism to do that per se, but everyone is encouraging it. It often happens and Jeff was one of those guys, created a big function where we spent a few years really focusing a lot of resources on trying to make clinical research to revolutionize it. And so that was, that was a great run for me. I did that for about three and a half years and then the company sort of switched gears to start trying to get some of these innovations in place so you can only dream for so long before you have to actually get some stuff done and apply it. Joe Kim (03:42): So there was a transformation that happened awhile back and I ended up moving into something called the design hub. In my role there for about a year was patient experience and design innovation, which is really about helping all the molecule teams figure out how to do things from a patient experience. Everything from awareness to recruitment to participation in learning. Anything we could do responsibly as it pertained to patients after the study, which is a thorny issue for a lot of good reasons. And then most recently in may, I moved into the digital health office shortly thereafter, started the podcast. So I'm always taking on new challenges and it's been a really great ride so far. Janet Kennedy (04:23): Well that's the definition of an exciting job, right? Where things are evolving and changing and new challenges come your way. But tell me what is the digital health office? Joe Kim (04:32): Yeah, the digital health office was born last year and it's basically a new team of a bunch of different kinds of folks, UX designers, developers, commercial strategists, and my group, which is translational technology and innovation and the remit has kind of evolved over time. It's a bit like a startup company within the company. And at first we were trying to figure out really the way to bring new digital health solutions to patients and doctors and health systems and that sort of thing. But we've also realized that you can't turn your back on digital health for drug development either. And so now we have these two sides of our work that we're really excited about and can reinforce each other. So for example, if you figure out a digital biomarker for a new way to measure drug efficacy, that could be repurposed as a, as part of a total digital health solution for a similar disease or something of that sort. Joe Kim (05:34): I can't talk in too much detail about those sorts of things, but I can give you some sort of hypothetical examples. So for example, if we think about asthma, is there a way you could forecast some sort of asthmatic flare using a bunch of different sensors and real world data and can you start to develop drugs that can alleviate those flares before they happen? Sounds great and you can use this to help the drug development process, but then it could also be part of a total digital solution where it's coupled with an inhaler or some sort of other mobile app that works in conjunction with the drug to do a lot more than just deliver medicine. We don't do anything in asthma, so I pick that as a safe topic. But you, you sort of can hopefully it gives you a sense of what the digital health office is here for Janet Kennedy (06:23): Would I be correct in assuming you're not trying to reinvent the wheel and design digital apps from the ground up, that you're actually looking for companies or startups to partner with to look at their technology? Joe Kim (06:36): Well, me personally, I don't do any of that actually. So translational technology and innovation is something slightly different, which I'll get into in a moment, but I'll say this much, as a company, we want to obviously use the best ideas and that doesn't mean we shut ourselves off from those ideas that are already out there in the world. We acquire companies, we in licensed compounds, and there's no reason why we wouldn't also consider external innovation as well. In fact, we just finished a external innovation challenge in IBD. That winner was selected last year. We actually have a podcast episode on that story itself, so you'll hear more about that hopefully in the next couple of weeks. Janet Kennedy (07:18): The IBD challenge was really fascinating and when I read through all the applicants, which I don't know, I'm even guessing 60 or more, they were so different from physical products to supportive apps, to medication delivery systems, to support groups and peer groups. It was fascinating how many different ways people imagined how to solve the problem of the IBD challenge. Joe Kim (07:43): Yeah, and that's a, that's a therapeutic area that hasn't gotten a lot of attention compared to something like diabetes, let's say with regard to helping patients use technology to help them manage their condition. So yeah, it was a good sort of new space for us and the general community to sink their teeth into. Janet Kennedy (08:03): All right. And I don't want you to have to give away any secrets here of your future podcast episode. But what was the technology that won? What was the idea? Joe Kim (08:11): It's mostly in the public domain. The technology was very simply a VR virtual reality format for children to focus their ability to understand their disease in a way that made sense to them. And specifically after some sort of colonoscopy or invasive procedure that they couldn't get their heads around and leaving that procedure in the fog that they're in. And then trying to learn about what just happened and understand the disease was just a big gap left in the whole health system. And that's no one's fault. It's just some unfortunate set of circumstances that leaves the patient kind of in the dark, so to speak. So this virtual reality application is supposed to really help a patient see exactly inside themselves and understand their disease up close and personal. Janet Kennedy (09:02): Well for children being sick is so frightening and some of the procedures they go through are uncomfortable if not painful. And the more they can try to understand at their level, the better off they're going to be. What was your role with the IBD challenge? Did that come out of your group? Joe Kim (09:19): No. So yeah, our group is pretty, pretty broad and it covers a bunch of different verticals that are required to bring digital health life. Our group is actually translational technology and innovation is really focused on sensor driven digital biomarker development. My team doesn't build apps. What we try and do is look for all the various sensors out there and you know, there are dozens of them. This is not just Fitbit and Apple watch. There's dozens of sensors out there that are all perfect, so to speak. Meaning they all behave a little bit differently. They have different combinations of sensors. They sample at different frequencies. Their battery lives are different, their charging modalities are different, their form factors are different. And what I mean by that, they're all perfect is depending on what you're trying to study, what you're trying to measure, there may be the right device for you. Joe Kim (10:09): Don't think that one device is perfect for all indications and sometimes there are these invisible so to speak. So the sensors that you don't have to wear but are monitoring you in the home. Well that's great too except you know many people leave their homes so for certain diseases and measurements it's not that useful. But if you're going to measure things that happen at night in the home then great. It's even better. So this is part of what our team does is make sense of all those sensors and help figure out new ways to measure things using those sensors. Our team is pretty diverse. It includes biomedical engineers, behavioral scientists, physician scientists, clinical research, operations professionals, data engineers. We're really excited about the team we've put together. I think for too long it's been teams that are just commercially focused or teams that are just technology focused or teams that are just sort of clinical research focused. We believe you can't do this properly unless you have that multidisciplinary team and everyone needs to start learning about each other's worlds because you can't just throw a Fitbit in a study and expect to make hay out of that. If you don't do it responsibly rigorously and understand exactly what you're getting into. Janet Kennedy (11:26): All right, so that leads me to a bookend to question. One is it kind of starts with as you refer protocol design that that if the study isn't written to accommodate this digital technology, then it's kind of hard to squeeze it in later in the trial. You're now working with patients. So I'm curious about protocol designers. Are they part of your team and how are you engaging patients in the evaluation and use of any of this technology? Joe Kim (11:54): To the extent that we are all sort of that protocol designers aren't a role and that we all design them as teams. Yeah, so as a team, because we're focused on this squarely and not, I say this with respect, not distracted by developing a medicine. We're all hired just to do digital biomarker work. We do this together. As you can imagine sometimes doing this early work is a square peg in a round hole, so we've had to really work the system to make sure that the other controls that are around protocol development for us to do this responsibly are sort of dialed into what we're trying to do. We're not giving some money an interventional drug where we don't have to look for a safety signal for that interventional drug. So there's lots of different nuances there. We work hard to really figure out how this will land operationally or pragmatically for a patient, particularly if we do it virtually, and we do a lot of virtual trials too, which is easier to do now because there's no drug, there's no medical procedures. Joe Kim (12:59): In short, you're mailing them a device or devices to where and they have to use apps to participate in the research and the data that gets pulled passively. But as simple as that is, it can be quite a learning process when you start to deploy these things. Something as simple as the way a question is ordered either together on the screen or not can create a lot of confusion. Or you know, if the battery is not charged and they don't know that it's not charged and the data's not streaming to the phone, right? There's only so much all devices can store certain amount of data before it stops collecting. Totally. So then you can end up with these empty spaces of data. It really depends on what you're trying to measure. So if you're trying to measure sleep, maybe a wrist worn thing isn't all that necessary. I don't care about what's happening during the waking hours. You should wear something only at night when it charged during the day. But if you're measuring something like activity and exertion, well then you can take it off at night, right? These are just simple ways to think about it. So it really starts with what you're trying to measure and then you try and design the experiments. Janet Kennedy (14:06): It sounds exciting. This cross functional team that really has kind of a whiteboard open to new innovation ideas. I love that. But it seems to me that's not going to happen unless your C suite is on board. So is this top down or did you guys push up and say we need to have this? Joe Kim (14:26): Yeah, this was a top down approach. Well, not from the very top of the very top. You know our C suite styled into this. It's not easy to just start a new thing called a digital health office and have that be publicly known. So when that happens you can bet that it goes all the way up to the top. You did ask another question around like how we get patients involved. Fortunately here at Lilly we have a pretty good history bringing patients into our drug development design work. You may have heard of something called Co-Lab or Co-Design. It's still happening now, but two of my great colleagues, Megan Laker and Susan Gilchrist, they are at Lilly running that capability now. We actually have a podcast episode on that too. I think it might be podcast number 11 at any rate, and we go into a deep dive of what that actually looks like, but in a nutshell, what that means is we literally bring patients into the company and we sit them down with the scientists and other site personnel and we work through the real issues of how this research may play out on people's lives. Joe Kim (15:32): We start off with a whole empathy session around, you know, what is a day in the life, a week in the life, a year in the life as it pertains to a study and really try and overlay some study design concepts and see where some of these things match up or don't. There's not like a recipe to it. It's really, it starts with empathy and listening and then really great dialogue around trade offs, which surveys can't do, right? You can't do this through a questionnaire or discussion board. It's gotta be live. It's messy. So we'll be using that framework as well or some version of that and just riding their coattails because they've been doing this for a while now. Janet Kennedy (16:12): Well, I understand you also had a podcast episode that I listened to having to do with matching up employees at Eli Lilly who had very serious health issues with individuals in other countries and they did a program together. So you know internally you have your own small ecosystem of people as patients. Joe Kim (16:34): Yeah, that was a very interesting episode. Terri Wingham, she was our guest on the episode. She's the founder of a company called A Fresh Chapter and she connects cancer survivors and brings a few from Lily and we go to developing country who needs help in some way and everyone pitches in and it's just a different way to continue one's healing. Yeah, that was a, that was a really amazing episode. Yeah, you should. You should check it out. It sounds like you did, but others should check it out if you haven't hadn't heard it. Janet Kennedy (17:06): Well, every episode you mentioned, I will put a link into this podcast so people can click right over there and see it. And yes, I love that idea that you are a global company, but it was very, very cool that you had your own employees who had had that serious health experience really going and working with folks in another area which made them feel so much more empowered so much outside of themselves. The problem with any health issue, and it's different for everyone, you get so focused on your own health is sometimes you kind of lose sight of the bigger picture. And this sounded like all of those folks really grew and benefited from the experience. Joe Kim (17:50): yeah. And these connections with patients get very deep and we need more folks in the company to build the right kind of relationships where possible. For example, myself, for a long time I've been building relationships with patient influencers and I gotta be honest. While it made sense to me sort of intuitively for awhile I was struggling with the quote unquote business value of doing that because if I was not responsible enough I could step on a landmine, but when the podcast came up as an opportunity and we really thought about what kind of guests we wanted to share, it was clear to us that in a lot of the other science podcasts out there, there was a lot of scientists on there and that's great, you want, you want experts on there, but there was a lack of the patient representation and we decided that that's a voice we wanted to amplify more and we wanted to bring them on together with scientists often to have a deeper dialogue around the state of medical advancements in that specific disease and what's on the horizon. Joe Kim (18:58): I think it's rare that many patients get to sit down with a leading scientist in that field to have some sort of exchange there. To bring it full circle, all of these patients that I've been sort of building relationships with. All of a sudden now I had people to call on and say, Hey, would you like to be on this podcast to talk about this disease that I know you're an influencer or you have a strong audience for? And because I've built that investment, I made that personal investment over the last five or six years. I wasn't coming in cold as some weird pharma guy, Hey, would you like to be on my podcast? And everyone was just super gracious and if they can fit it in, they did. I have plenty more I want to have on the show. It's really great now that wow, there is a quote unquote business value to me, building relationships with patient influencers. They're happy to talk to me on the podcast, which is, which is fantastic. Janet Kennedy (19:56): Well, I was noticing that the last episode of your first season, Episode 11 is the promise of genetic innovation and cracking the code of ALS as a lay person, not a scientist and not a medical professional, I'm coming at my information to medicine literally through social media, through podcasts, through posts that people put up there and I did think this was fascinating that you had both Brian and Sandra with I AM ALS representing a patient centric viewpoint coming on your podcast and then you also spoke to your Lilly scientist Andrew Adams about some very sciency stuff. That's something I will admit I can't pull off, but I love the fact that you are able to be the interpreter for both groups, enabling patients to speak to scientists and scientists to explain to patients the complexities of of these diseases. Joe Kim (20:48): We partly just got really lucky there in terms of the timing because Brian was in town, but he's really well known in the Alice community and Andrew is just focused on some really exciting genetic modalities to think about helping a number of diseases because this isn't just focused on neurodegeneration. We really want to try and do more of that where we get patients to actually sit down and because they were there across the table from each other and it was really great to have that kind of interaction. We may even do it a little bit more purposefully and just have it just be about the disease and where it's going from a medical, scientific perspective. Certainly not every episode needs to be that way, nor nor do we want to always do those things, but the more we can do that, I think that's a really exciting format because you don't see that. I haven't come across the science podcast that way either. So yeah, this has been super exciting to do. Looking forward to the next several episodes coming up, Janet Kennedy (21:44): You had 11 episodes in your first season. Are you going to do this quarterly, semi-annually? What? What's your plan for the podcast? Joe Kim (21:52): We only launched in May, I think we recorded earlier than that. I think we're really going to shoot for once a month and we've already started recording late last year and early this year because of who we are. It has to go through a pretty rigorous process to make sure we're not getting into trouble for saying the wrong sorts of things, but you know, we're not talking about products. We're really just talking about stories that inspire scientific advancement. We can all identify with some of these diseases because there are people in our lives to have these things. Nearly everything that's been on the show, you know, I've, I've had some sort of personal connection with one of these illnesses. It's great to use some of my background that I've ditched in my early career. I was a science teacher and while I loved to teach working in a school environment, a traditional school environment was just, it didn't fit me. But to your point about having scientists and patients come together, they don't often talk the same language. I mean patients are really sophisticated now, but there is a certain level of biology that if you understand it more deeply, you'll get even more out of it. And then scientists, they've been talking to each other for so long, you know, they're using $5 words that no one else really uses. So if I can be that interpreter, that's really a great place for me to be. Janet Kennedy (23:12): And that's a challenge, not just on the pharma side. That's a challenge in healthcare when physicians are explaining issues to their patients, you know, are they speaking in plain language? Are they easily understood? As a matter of fact, I did an interview with your global health literacy person and that was the focus that we've got to put this information out in a way that people can understand it and take action with it. Joe Kim (23:37): Yeah, I mean just say the word rash, right. Don't, don't use the Latin words that that the five different Latin words that describe rash. Just saying rash. Right, or it works versus it's not working. Janet Kennedy (23:51): Absolutely. Well, tell me a little bit about where you think we're going in clinical trials. When you joined the pharma industry in the late nineties early two thousands you had one experience. If somebody were coming into the industry now, I'm sure it's a totally different experience. So over your 20 years or so, what do you see that has really changed in the industry? Joe Kim (24:14): The use of data to make decisions has been really transformational. I think I recall one of my earliest clinical trials I was working on and we were selecting which sites to go to. We literally had a stack of resumes that'd be go through and say A, B and C like yes, maybe no, which is not a great way to pick sites who might be useful or great at enrolling and conducting the trial. So even from a site selection standpoint, you're using more data to think about who's been really great in the past. Do they have access to patients? What does their demographic look like? So using a lot more data to do that. And then even further upstream thinking about medical informatics to design the patient eligibility criteria. So in the past you'd just be looking for, "give us all men who asked for directions when they're lost", right? Joe Kim (25:07): Not a lot, but now we have data to say, Hey, we want people on drug A not on drug B with this condition and not, and then let's see if that patient actually exists because that might be a perfect one for this study. But if they don't exist, this is not perfect for anyone. So we can use that kind of data to really find the right trade off between stringent enough criteria so that we find a signal, but at least have a enough abundance of patients. So those two things are been really game changing in terms of how we design protocols and set up the operations to do that. I think a lot of people are also thinking about this notion of a sightless trial or decentralized trial. I don't want to use the word virtual. I think that really means to trial without patients. Joe Kim (25:53): So like a simulated trial. So we should, as an industry get away from this virtual notion. I'm really think a bit more about these centralized to some degree or location flexible is probably more even more accurate. But it's the idea of how does a patient participate in the study without always having to go to the clinic. Janet Kennedy (26:11): How do you feel about the word hybrid? Joe Kim (26:14): Well, I'm not sure what you're hybriding what's the two, but really it's about flexibility and location. That's the name of the game. But you know, if you think about medical research as a set of medical procedures that all have to be done within a window, then you can really start to take apart this notion of a visit, visit, one visit to visit, three, forget to visit. Here are the procedures that need to be done, the activities. So you think of more of like an activity based set of medical procedures. Joe Kim (26:46): Now, which one of those can be done with telemedicine? Which one of those can be done with in home health, which can be done at a clinic, which can be done at retail, right? So not everything can be done at home. Not everything can be done through telemedicine. So it's really thinking about which ones can be done in a variety of, of ways. And even then we've discovered at Lilly through some of our research that a good healthy portion of patients don't want anyone coming into their home. They just don't, and I get that. My home is a mess. On Wednesday, I'd rather just go to the doctor. Now, do I want to go to the doctor to do a visit for three hours? No, but it'd be great to do what I can in that window if it takes me 30 minutes. That's how we have to start. You have to dismantle the visit construct and just think about individual activities. Janet Kennedy (27:35): Now you use the word retail. Are you actually thinking like someone going to a CVS or a Walgreens or a Walmart just to have a simple blood draw done or something like that? Joe Kim (27:45): Sure, that's possible. Right? It has to be done responsibly and rigorously, but even in some of our early pilots of flexible location trials, one of the drugs was marketed, so we were able to have patients pick it up from your local drug store instead of having them come into a site. Now this is a very different kind of study. It wasn't part of the efficacy trial, it was more real world evidence, but at any rate, it can be done under the right context. So it's really just about thinking under what context can X, Y and Z be done versus saying this can't be done, so you have to sort of pick and choose. Janet Kennedy (28:21): Are you seeing enough evidence that it's making a difference that it really can impact either the adherence levels of patients or the persistence of taking a drug by incorporating a variety of different ways to engage with a patient? Joe Kim (28:36): I think we are still trying to get good use cases under our belt. We being the industry in terms of what kinds of trials are fit for this kind of thing. The logical argument makes a lot of sense, right, so there is a logical argument there which is if you don't make it too inconvenient on a patient, they'll do more of it. Right? That's the very same thing to say. Now at the same time, there is a component of clinical research where the bond between the patient and the clinic staff is such that that's also a main contributor for why patients either stay in the study or are able to follow along what they're committed to do. Because you've got someone on the other end expecting you to cross all the T's and dot all the i's, and this is a, this is a component and behavior change. Joe Kim (29:31): There is a social component in behavior change and participating in research is behavior. Change is a social component that if that's there, you're more likely to have people stick to it when that's absent and there's no evidence of a larger connection with a person or people. Sometimes you could get really easy to drop off because guess what? No one's watching. No one cares. A research kit study came out years ago. Stanford, the heart health study. I joined that because it was super easy and I was able to do a lot of the stuff because I suppose super easy. I was walking my kids to the school. I did the six minute walk tests, but then after awhile I stopped doing some things. Now I get reminders. I ignore them. It was actually very easy to drop off without anyone calling me on the carpet. So you could argue that if you do everything virtually, you run the risk of people just disappearing because there's no commitment. There's no gym buddy. Right. To help keep you honest. Janet Kennedy (30:27): Right. Definitely. When we talk about patient engagement, a lot of people will think it's about pushing a button and really it's also making sure that that patient feels like their actions matter. Joe Kim (30:40): That's right. Janet Kennedy (30:41): Tell me a little bit about your road show when you hit the road in 2020 I know you're going to be doing some speaking engagements. What are the topics you're addressing this year? Joe Kim (30:51): Well, because of my role as squarely focused on digital health and sensor research, I have to be careful not to be swimming outside my lane, though I have some knowledge and experience with things and traditional drug research. It's not my role anymore, so I have to be careful to let my other colleagues to represent themselves or our company for those sorts of things and having me kind of stay in my swim lane. While I'm happy to do it, I have to do it with integrity, I guess. So I've actually pulled back a little bit because to be frank, I'm not an expert in digital health and sensor research. I'm an amateur here and that's partly why I took the role is I want to be the dumbest guy in the room. Let me learn and get up to speed and grow my skillset and knowledge base. So I'll do a lot more listening actually this time around. But there's plenty of me on the airwaves through the podcast, so hopefully people aren't going to miss me too much. Janet Kennedy (31:49): Well, I think it's going to be a very exciting year, 2020 or 2020 whatever you want to call it. We're going to have, I think a lot of interesting changes come about as we finally fish or cut bait and we, as an industry, really start to include digital health and new technologies into the clinical trial process. 'm very excited about what's going to be coming up in the next year or two. Joe Kim (32:17): Yeah, me too. I think this notion of digital biomarkers is a key enabler of decentralized trials, right? So one thing that anchors people or science to the clinic is the fact that an endpoint needs to be done by somebody in person. And as long as that happens, you're not going to enroll somebody a hundred miles away. They have to be within a driving distance, reasonable driving distance, except for some exceptions like rare disease and oncology. But for the most part, if you're not in a reasonable driving distance, you're not going to enroll because the primary end point has to be done at the clinic. What digital biomarkers enable is for that to be done remotely through a sensor and now you're not tied to the clinic if you don't want to be. Now I'm generalizing, it's not going to happen for every single kind of study, but that is one thing that is definitely anchoring research to the clinic. So the more digital biomarker work we can get, the faster we can get to decentralized flexible location trials. Janet Kennedy (33:18): Absolutely. Well, I'm voting for that, and I really hope that that's going to be something that becomes much more of a reality going forward so that we can get much better representation in diverse communities and in rural communities involved in our clinical trials. New Speaker (33:34): Yeah, likewise. Janet Kennedy (33:35): Well, I can't thank you enough for being part of this podcast. Joe, you've been listening to "People Always, Patients Sometimes" with my guest, Joseph Kim, who's the senior advisor, digital health office, translational technology and innovation for Eli Lilly. Thank you so much for being here, Joe. Joe Kim (33:51): Thanks for having me, Janet. It was a lot of fun. 

Perhaps there is a better way for both of us to have what we want, occasionally, and eat better 90 percent of the time. We gotta pay attention to both mental and body systems. We have to focused on taking care of the brain and brain functions. One of the ways we do that is by making better food and nutritional choices. So in this episode, a really simplistic definition of oxidative stress and some of the foods and supplements that can keep the free radicals in our bodies from gunking up the works. If you need support contact the National Suicide Prevention Lifeline at 1-800-273-8255, the Trevor Project at 1-866-488-7386 or text “START” to 741-741. Resources Mentioned:  The Cleveland Clinic has a page on 7 Tricks to Manage Anxiety. Author Veronica Roth has an opinion piece in the New York Times about going off her anti-depressant medication under stay at home orders The Breethe (double ee) app is available via the Apple and Google app stores. There is also a Breethe YouTube channel that answers some questions about meditation, Vitamins and Mineral Fact Sheet from the International Food Information Council Foundation. National Institute of Health - Office of Dietary Supplements Vitamin B6 Fact Sheet Vitamin C Fact Sheet Vitamin E Fact Sheet Lycopene via the International Food Information Council Foundation Dr. Uma Haidoo's article at Harvard Health on Nutritional Strategies to Ease Anxiety.    Disclaimer:  Links to other sites are provided for information purposes only and do not constitute endorsements.  Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment.

On this edition of Swiss Up, Dario looks at the work of the Swiss Federal Office of Public Health - and the head of the communicable disease division, Daniel Koch - who's now a household name in Switzerland.

~ Welcome to the Ladybugging STEM podcast! Hosted by Abby, a biomedical engineering undergraduate student at Vanderbilt University, the show interviews incredible women in STEM, solving problems in STEM. ~This episode's guest is Elizabeth (Betsy) Wilder, PhD. She is currently the Director of the National Institutes of Health Office of Strategic Coordination, and has done research in the past in molecular and cell biology as well as developmental genetics. Now, she works to fund the future of scientific research. In this episode, we talk about graduate school, the ups and downs of research, and the future of the science community. Follow the Ladybugging STEM podcast on social media:Instagram: @ladybuggingstemTwitter @ladybuggingstemFacebook: Ladybugging STEM: The Podcast-- music: “Upbeat Party” by scottholmesmusic.com --

In this episode, we hear from the Director of Special Programs, Ms. Amanda Keil, who explains all of the program options available including before and after school care, Plus Program, enrichment, and clubs. Next, Assistant Head of School Mrs. Pam Hoeffner talks about arrival and dismissal routines that help to keep our students safe. Nurse Kelly Gregory reminds families about some important information from the Health Office. And lastly, we end the podcast with a bit of fun to get our brains warmed up for the new school year. It’s a game of trivia with three of our teachers: Ms. Teresa Burke, Mrs. Anna Gabree, and Mrs. Stephanie Haines!

Like magnesium, zinc is a mineral that’s present in many of the body’s functions. We talked about Magnesium in another episode and if you remember it’s important because it’s involved in many different ways in your body’s cellular activity. Well zinc is another much needed mineral and let’s talk about why! EPISODE SCRIPT Zinc might not be as ubiquitous as magnesium, but it’s still very important to pay attention to in your diet. Why? Because the body lacks a specialized zinc storage system! Zinc has a lot of benefits, but three in particular can have a big impact on your daily health. First, zinc supports your immune system. While you only need a little zinc to have your immune system work well, a deficiency could have dire consequences. That’s because zinc is the ingredient necessary to activate T-cells, which are important for two reasons: 1) T-cells attack infected and cancerous cells and 2) they help to control and regulate immune responses. A measure of how important T-cells are for the immune system is that some of the worst aspects of HIV result from the virus’s attack on T-cells. Second, zinc has an impact in the process of healing wounds. Specifically, it’s important because of the way it interacts with collagen. Collagen is a protein that maintains the structure in skin and other kinds of connective tissue. Zinc, in turn, helps in the production and remodeling of collagen, which is a key property that boosts tissue growth in and around a “wound bed,” thus promoting healing. Third, zinc has great properties that can help you with the common cold. Many people find that zinc lozenges can help cut down on the severity and duration of a cold. One study found this zinc remedy could cut down on the length of a cold by 40 percent! The theory is that zinc helps to reduce inflammation in and around the mouth and throat, where much of the cold virus resides. So, now that you know that you need zinc, where can you find it? Oysters are a great source, so if you’re at happy hour, have a few to make up for that beer! Red meat, lobster and poultry are also good sources. For vegetarians, beans, nuts, dairy products and especially whole grains help with zinc intake. Since zinc isn’t stored in the body, people who are prone to zinc deficiencies either have trouble absorbing it, take in too little, or use up too much. In the first case you’ll find people with digestive disorders or diseases associated with metabolism, like liver disease. In the second case, vegetarians who aren’t eating oysters and red meat could become zinc deficient without some compensating strategies. Women who are pregnant or breastfeeding use a lot of zinc for their baby’s needs and may also run low. Remember, because your body can’t store this important mineral, don’t take it for granted. Think zinc. Key Terms and Ideas: The only source of zinc comes from what we eat (either from food or supplements) because the body lacks a specialized zinc storage system. T-cells are a “type of white blood cell that is of key importance to the immune system and is at the core of adaptive immunity, the system that tailors the body's immune response to specific pathogens. The T cells are like soldiers who search out and destroy the targeted invaders.” (MedicineNet) Collagen is a protein that maintains the structure in skin and other kinds of connective tissue. LINKS & RESOURCES: Cathy Thomas Hess, "Monitoring laboratory values: zinc, copper, vitamin C, vitamin A, and vitamin E," Advances in skin & wound care 22.5 (2009): 240, https://journals.lww.com/aswcjournal/Citation/2009/05000/Monitoring_Laboratory_Values__Zinc,_Copper,.12.aspx, accessed April 2019. Joseph Nordqvist, “What are the health benefits of Zinc?” Medical News Today, December 5, 2017, https://www.medicalnewstoday.com/articles/263176.php, accessed April 2019. William S. Shiel, “Medical Definition of T Cell,” MedicineNet, https://www.medicinenet.com/script/main/art.asp?articlekey=11300, accessed April 2019. “Zinc: Fact Sheet for Health Professionals,” National Institutes of Health: Office of Dietary Supplements, March 13, 2019, https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/, accessed April 2019. Follow Dr. Nada on: Linkedin https://www.linkedin.com/in/nada-milo... Sage Tonic www.sagetonic.com Sage Tonic on Instagram https://www.instagram.com/sagetonic/ SUBSCRIBE: Apple Podcasts: http://bit.ly/SpartanUpShow YouTube: http://bit.ly/SpartanUpYT Google Play: http://bit.ly/SpartanUpPlay FOLLOW SPARTAN UP: Spartan Up on Instagram https://www.instagram.com/spartanuppo... Spartan Up on Twitter https://twitter.com/SpartanUpPod CREDITS: Producer: Marion Abrams, Madmotion, llc. Writer and Host: Nada Milosavljevic MD, JD © 2019 Spartan

Dr Wayne Jonas is a pioneer in integrative, healing-based, patient-centered healthcare who has been at the nexus of healthcare and healing for over 40 years. He served as director of the National Institutes of Health Office of Alternative Medicine in the 1990s, as well as leading the World Health Organization's Collaborative Center for Traditional Medicine.

Now days everybody is trying to help you by selling you something. You don't have to accept or reject everything you read but you can take the time to check it out. In this quick episode, a look at Bananas, can they help you with symptom control or not? If you need support contact the National Suicide Prevention Lifeline at 1-800-273-8255, the Trevor Project at 1-866-488-7386 or text “START” to 741-741. Music in this episode is from https://www.purple-planet.com Resources Mentioned:  National Nutrition Databases for Standard References on Bananas, State of Massachusetts Public Health Blog has an post about bananas and four other foods that can help boost moods. National Institute of Health Office of Dietary Supplements has a consumer friendly page about Vitamin B6 which for those of us that have problems with depression could be interested in reading more about it. If you must go the distance with this then check out the Banana Kale Smoothie. Those of you on Keto, Paleo or Low Carb look away. Disclaimer:  Links to other sites are provided for information purposes only and do not constitute endorsements.  Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment. not?  

NASN School Nurse Editor, Cynthia Galemore, interviews authors Tami L. Jakubowski and Tracy Perron about their article "Asthma Assessment in the School Health Office: Can They Stay or Should They Go?"  To view the article, click here.

Wayne B. Jonas, M.D. is a practicing family physician, an expert in integrative health and health care delivery, and a widely published scientific investigator. Dr. Jonas is the Executive Director of Samueli Integrative Health Programs, an effort supported by Henry and Susan Samueli to increase awareness of and access to integrative health. Additionally, Dr. Jonas is a retired Lieutenant Colonel in the Medical Corps of the United States Army. From 2001-2016, he was President and Chief Executive Officer of the Samueli Institute, a non-profit medical research organization supporting the scientific investigation of healing processes in the areas of stress, pain and resilience. Dr. Jonas was the Director of the Office of Alternative Medicine at the National Institutes of Health (NIH) from 1995-1999, and prior to that served as the Director of the Medical Research Fellowship at the Walter Reed Army Institute of Research. He is a Fellow of the American Academy of Family Physicians. Dr. Jonas has led and participated in hundreds of research studies beginning with his time as Director of the National Institutes of Health Office of Alternative Medicine. While serving as CEO and President of the non-profit research organization Samueli Institute, his work set the bar for evidence-based research in the areas of pain, stress and human performance. Dr. Jonas' new book, How Healing Works, was published in January 2018 by Ten Speed Press. His research has appeared in peer-reviewed journals such as the Journal of the American Medical Association, Nature Medicine, the Journal of Family Practice, the Annals of Internal Medicine, and The Lancet. Dr. Jonas received the 2015 Pioneer Award from the Integrative Healthcare Symposium, the 2007 America's Top Family Doctors Award, the 2003 Pioneer Award from the American Holistic Medical Association, the 2002 Physician Recognition Award of the American Medical Association, and the 2002 Meritorious Activity Prize from the International Society of Life Information Science in Chiba, Japan. Dr. Wayne Jonas explains how 80 percent of healing occurs organically and how to activate the healing process. Dr. Wayne Jonas lays out a revolutionary new way to approach injury, illness, and wellness; explains the biology of healing and the science behind the discovery that 80 percent of healing can be attributed to the mind-body connection and other naturally occurring processes. Dr. Jonas also details how the healing process works and what we can do to facilitate our own innate ability to heal. His advice will change how we consume health care, enabling us to be more in control of our recovery and lasting wellness. Helpful links and resources: "How Healing Works" Book : http://howhealingworks.org Website: http://drwaynejonas.com Patient and provider resources: http://drwaynejonas.com/resources/ Facebook and Twitter: @DrWayneJonas

Wayne B. Jonas, M.D. is a practicing family physician, an expert in integrative health and health care delivery, and a widely published scientific investigator. Dr. Jonas is the Executive Director of Samueli Integrative Health Programs, an effort supported by Henry and Susan Samueli to increase awareness and access to integrative health. Additionally, Dr. Jonas is a retired Lieutenant Colonel in the Medical Corps of the United States Army. From 2001-2016, he was President and Chief Executive Officer of the Samueli Institute, a non-profit medical research organization supporting the scientific investigation of healing processes in the areas of stress, pain and resilience.Dr. Jonas was the Director of the Office of Alternative Medicine at the National Institutes of Health (NIH) from 1995-1999, and prior to that served as the Director of the Medical Research Fellowship at the Walter Reed Army Institute of Research. He is a Fellow of the American Academy of Family Physicians.Dr. Jonas has led and participated in hundreds of research studies beginning with his time as Director of the National Institutes of Health Office of Alternative Medicine. While serving as CEO and President of the non-profit research organization Samueli Institute, his work set the bar for evidence-based research in the areas of pain, stress and human performance.His research has appeared in peer-reviewed journals such as the Journal of the American Medical Association, Nature Medicine, the Journal of Family Practice, the Annals of Internal Medicine, and The Lancet. Dr. Jonas received the 2015 Pioneer Award from the Integrative Healthcare Symposium, the 2007 America’s Top Family Doctors Award, the 2003 Pioneer Award from the American Holistic Medical Association, the 2002 Physician Recognition Award of the American Medical Association, and the 2002 Meritorious Activity Prize from the International Society of Life Information Science in Chiba, Japan.

What does the pending Individual Mandate mean for insurance options and membership medicine. What is the best way to market you membership medicine practice (medicine for the masses or the select few) and why should shop local for your construction rental equipment needs. Song of the Week - I Want a Hippopotamus for Christmas - Gayla Peevey Concierge medicine specialists tackle everything from Obamacare to Breaking Bad in this one-of-a-kind podcast. The most listened concierge medicine podcast in America is hosted by Dr. Tommy and Tracy McElroy. Dr. Tommy is the founder of Echelon-Health which provides concierge medicine, fitness, and nutrition services to those living in greater Tampa, Florida. Dr. Tommy TV: https://www.youtube.com/c/askdrtommy Echelon-Health YouTube: https://www.youtube.com/c/Echelonhealth Echelon-Health Concierge Medicine: http://echelon-health.com Dr. Tommy Online: http://askdrtommy.com Twitter: https://twitter.com/tampadirectcare Echelon-Health Facebook: https://facebook.com/tampadirectcare Dr. Tommy Facebook: https://facebook.com/askdrtommy

Conversation with Clinical Development Veteran Marshall Cool “There are a lot of things we can do, but we want to make sure we’re doing what we want to do” - Marshall Cool In this interview, I talk to one of my dear friends Marshall Cool, who also turns out to be a clinical research veteran. Marshall brings to us his over two decades of clinical development experience, including his time at Abbott Vascular, leading one of the most exciting post-approval medical device studies, XIENCE V USA. Marshall also has significant experience managing Investigator Sponsored Studies (ISS) and clinical research organizations, details of which he shares with us during this interview. In addition, Marshall is an avid reader and loves books. Please enjoy my conversation with Marshall Cool. Listen to it on iTunes.Stream by clicking here.Download as an MP3 by right-clicking here and choosing “save as.” Selected Links from the Episode: Connect with Marshall Cool LinkedIn CSU Annual Biotechnology Symposium Bristol-Myers Squibb Abbott Seth Godin Blog Center for Disease Control National Institute of Health Office of Inspector General Medical Affairs Strategic Summit (West) Medical Affairs Strategic Summit (East) ACRP Investigator Initiated and Sponsored Research Interest Group Books Mentioned: The Road to Character by David Brooks Chronicles of Narnia by C.S. Lewis and Pauline Baynes Linchpin: Are You Indispensable by Seth Godin The Checklist Manifesto: How to Get Things Right by Atul Gawande Show Notes: Description of what a clinical researcher does [02:10] Early days in clinical research [04:23] Roles and responsibilities of a clinical research associate (CRA) [08:55] You don’t need an M.D. or Ph.D. to be in clinical research [10:55] Relocating for jobs [13:20] Transition from pharma to medical device clinical trials [15:55] What to do when you lose your job [19:46] Getting into the habit of reading and how it can help your clinical research job [26:31] Getting to First Patient In (FPI) for a post-approval medical device study [31:50] Onboarding a clinical research organization (CRO) [39:15] Investigator sponsored studies (non-company sponsored research) [41:30] Starting your career in Phase I-III research [45:45] Marshall’s #1 advice to listeners [56:30] My motivations for starting the Clinical Trial Podcast [1:01:33] QUESTION: What was your favorite lesson from this episode? Leave me a comment below and thanks for listening.  

Still on the vacation and revision track, there will be occasional episodes until the fall. In this episode, a look at having an panic attack in 30,000 feet up and what is the deal about the mineral magnesium? If you're having suicidal thoughts, contact the National Suicide Prevention Lifeline for immediate help: 1-800-273-TALK (8255) Resources Mentioned: Huff Post article on Panic at 30,000 Feet, Is there A Dentist In the House? Verywell post on Managing Panic Attacks While Flying The Mighty 22 Unexpected Relaxation Techniques  Lisa Jacob's new book It is Not Just Me; Anxiety Depression and Learning to Embrace your Weird.   Chiropractor Eric Berg has a good explainer video about the importance of breathing for sleeping and also for stress reduction.  Medline Plus Medical Encyclopedia Magnesium in Diet U.S. National Institute of Health Office of Dietary Supplement’s page on magnesium, what it is, the benefits and drawbacks and how much should you consume. University of Maryland Medical Center - Complementary and Alternative Medicine Supplement Guide on Magnesium   Disclaimer: Links to other sites are provided for information purposes only and do not constitute endorsements. Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment.   

Ellice is a sweet friend from Cedarburg, WI  I met in Brooklyn. She makes me laugh and feel loved. Image: Structures in Japan Follow along with these gorgeous tracks: TRACK 1: Intro Themesong by Danny Townsend TRACK 2: Circlesong “Christmas Day” by Ben Weber TRACK 3: Intro by Ben Weber TRACK 4: “Cozy Zoning” by Ellice Plant and Ben…Read more EPISODE 52: Ellice Plant in the Brooklyn Whole Health Office SIDE E

Ellice is a sweet friend from Cedarburg, WI  I met in Brooklyn. She makes me laugh and feel loved. Image: Paper Trees Follow along with these gorgeous tracks: TRACK 1: Intro Themesong by Danny Townsend TRACK 2: Circlesong “Earth and Aether” by Ellice Plant, Katie Grimm, Nicolette Dixon, and Ben Weber TRACK 3: Intro by Ben Weber TRACK 4:…Read more EPISODE 52: Ellice Plant in the Brooklyn Whole Health Office SIDE D

Ellice is a sweet friend from Cedarburg, WI  I met in Brooklyn. She makes me laugh and feel loved. Image: Wisconsin or Japan? Follow along with these gorgeous tracks: TRACK 1: Intro Themesong by Danny Townsend TRACK 2: Circlesong “Cumbia” by Ben Weber TRACK 3: Intro by Ben Weber TRACK 4: State Your Problem TRACK 5: Teacher Self TRACK 6: Constellation…Read more EPISODE 52: Ellice Plant in the Brooklyn Whole Health Office SIDE C

Ellice is a sweet friend from Cedarburg, WI  I met in Brooklyn. She makes me laugh and feel loved. Image: A View from Ellice’s Nice Office Bathroom Follow along with these gorgeous tracks: TRACK 1: Intro Themesong by Danny Townsend TRACK 2: Circlesong “Collom Balem” by Ben Weber TRACK 3: Intro by Ben Weber TRACK 4: Embracing the Chaos…Read more EPISODE 52: Ellice Plant in the Brooklyn Whole Health Office SIDE B

Ellice is a sweet friend from Cedarburg, WI  I met in Brooklyn. She makes me laugh and feel loved. Follow along with these gorgeous tracks: TRACK 1: Intro Themesong by Danny Townsend TRACK 2: Circlesong “Skylight” by Ben Weber TRACK 3: Intro by Ben Weber TRACK 4: My Office TRACK 5: Treatment TRACK 6: Ayurveda TRACK 7: Outro by Ben…Read more EPISODE 52: Ellice Plant in the Brooklyn Whole Health Office SIDE A

You as a health care consumer have to know what you are taking, the possible side effects and interactions with the foods you eat and other medications you have know that the good stuff does not necessarily come cheap or is high priced. There are resources you can use to help you make an informed decision.     Resources Mentioned: Johnny B. Truant's The Universe Doesn't Give A Flying Fuck About You University of Chicago Tang Center for Herbal Medicine Research page on Kava  Harvard Health Publications Women's Health Watch page on Kava and Inositol Carrie Ramsdell's Kava Information Graphic NCCIH page on Kava National Institute of Health Office of Dietary Supplements -  What you need to know before your buy FDA warning about Kava if you have a liver condition Dietary Supplement Label Database you type in your herb or mineral of choice; it will show you various vendor products and you can drill down to what you want or need in a supplement   Disclaimer: Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment

Women’s health pioneer Dr. May Cohen will soon join other luminaries in the Canadian Medical Hall of Fame. Cohen entered medicine at a time when less than 10% of graduating physicians were female and textbook medical research was based on a 70kg male body. She later went on to shatter that paradigm, co-founding Canada’s first Women’s Health Office at McMaster University, as well as the Women’s Health InterSchool Curriculum Committee for Ontario medical schools. Cohen joins CMAJ reporter Lauren Vogel to reflect on the changing status of women in medicine.

As a near death experience survivor, Aimee has a unique outlook about life in general. A skilled teacher, author, lecturer, both on radio and television, she sees and hears energy and patterns in a client’s life which, when brought to conscious awareness, enable a person to deal with their life very differently.  Aimee is one of a very few in the world that teach and practice the Axiatonal Light Grid, an energy work that calls in the soul’s original intention to be physical. When that memory is (re-)called into present space and time, the client’s outlook, life and quite simply, the way they participate in the world changes.  She's the author of "Facts Are Beliefs Made Solid." She was a founding member of the National Institutes of Health Office of Alternative and Complementary Medicines, is a medical intuitive, and an advocate for alternative medicines.  Aimee has lectured and led meditations at the United Nations S.R.C. (staff recreation council) Enlightenment Society, for spiritual awareness.  Check out her website at  http://www.elighten.org  She is also the publisher of http://LoveRising.info, which is a rich resource of information and alternative technologies for forward thinking people. At the top of the show, it's Anastasia's Starseed News, bringing topics of interest to starseeds that you won't hear in the mainstream news! Thanks to Fiona, Vania and Klaudija for their ongoing contributions to Starseed Radio Academy in hosting the switchboard!

Dr. Robert Kaplan, Director of the National Institutes of Health Office of Behavioral and Social Sciences Research, and Dr. Barbara Barry, research scientist with the Northeastern University Relational Agents Group, discuss the evolving role of technology in addressing the behavioral aspects of health. These ideas will be further explored at an event on Friday, March 22, at the New York Academy of Sciences titled Health 2.0: Digital Technology in Clinical Care. This conference is jointly presented by The New York State Department of Health AIDS Institute, The Josiah Macy Jr. Foundation, and the New York Academy of Sciences. Dr. Robert Kaplan, Director of the National Institutes of Health Office of Behavioral and Social Sciences Research, and Dr. Barbara Barry, research scientist with the Northeastern University Relational Agents Group, discuss the evolving role of technology in addressing the behavioral aspects of health. These ideas will be further explored at an event on Friday, March 22, at the New York Academy of Sciences titled Health 2.0: Digital Technology in Clinical Care. This conference is jointly presented by The New York State Department of Health AIDS Institute, The Josiah Macy Jr. Foundation, and the New York Academy of Sciences.

Mary Molina Mescall talks about the making of the New Mexico Governor’s Women’s Health Office and the proclamation of Women’s Health Week, May 10-16. For the full schedule, visit nmwellwoman.com. The press conference took place at the University of New Mexico Student Union Building.

The New Mexico Governor’s Women’s Health Office and University of New Mexico Creative Writing Program present the winners and finalists of the New Mexico Well Teen Poetry Prize. The event is part of Women’s Health Week, May 10-16. For the full schedule, visit nmwellwoman.com.